LONDON--(BUSINESS WIRE)--Jonathan Harrison has joined Houlihan Lokey as a Managing Director in the Business Services Group, based in London.
Reported by Business Wire 46 minutes ago.
Houlihan Lokey’s Business Services Group Adds Highly Experienced Managing Director in Europe
↧
↧
Net Asset Value(s)
*WisdomTree Issuer plc – Daily Fund Prices * *16-October-18*
* * * *
WisdomTree AT1 CoCo Bond UCITS ETF – USD 16/10/2018 IE00BZ0XVF52 328045 USD 31,399,731.42 95.7178
WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 16/10/2018 IE00BFNNN236 20828 EUR 2,065,997.95 99.1933
WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 16/10/2018 IE00BFNNN459 20740 GBP 2,062,429.16 99.4421
WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc 16/10/2018 IE00BZ0XVG69 9000 USD 865,297.71 96.1442
WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged 16/10/2018 IE00BFNNN012 20962 USD 2,088,813.17 99.6476
WisdomTree CBOE S&P 500 PutWrite UCITS ETF - USD Acc 16/10/2018 IE00BD49R243 1680000 USD 84,929,384.73 50.5532
WisdomTree Emerging Asia Equity Income UCITS ETF 16/10/2018 IE00BYPGT035 1125000 USD 11,938,197.77 10.6117
WisdomTree Emerging Markets Equity Income UCITS ETF 16/10/2018 IE00BQQ3Q067 2042097 USD 30,613,416.43 14.9912
WisdomTree Emerging Markets Equity Income UCITS ETF Acc 16/10/2018 IE00BDF12W49 108242 USD 2,050,911.98 18.9475
WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJBM26 1375000 USD 21,818,183.67 15.8678
WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc 16/10/2018 IE00BG88WG77 25000 EUR 257,205.71 10.2882
WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc 16/10/2018 IE00BG88WH84 1325000 GBP 13,657,621.72 10.3076
WisdomTree Enhanced Commodity UCITS ETF - USD 16/10/2018 IE00BZ1GHD37 525000 USD 5,689,709.19 10.8375
WisdomTree Enhanced Commodity UCITS ETF - USD Acc 16/10/2018 IE00BYMLZY74 12450000 USD 135,522,711.02 10.8854
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR 16/10/2018 IE00BD49R912 30000 EUR 1,478,620.50 49.2874
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc 16/10/2018 IE00BD49RB39 30000 EUR 1,478,621.48 49.2874
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF 16/10/2018 IE00BD49RJ15 30000 EUR 1,464,658.87 48.822
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc 16/10/2018 IE00BD49RK20 30000 EUR 1,464,659.24 48.822
WisdomTree Europe Equity Income UCITS ETF 16/10/2018 IE00BQZJBX31 3548600 EUR 44,743,899.80 12.6089
WisdomTree Europe Equity Income UCITS ETF Acc 16/10/2018 IE00BDF16007 40010 EUR 576,074.23 14.3983
WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZT11 17096 CHF 270,930.89 15.8476
WisdomTree Europe Equity UCITS ETF - EUR Acc 16/10/2018 IE00BYQCZX56 1304306 EUR 20,982,916.82 16.0874
WisdomTree Europe Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BYQCZQ89 372454 GBP 3,932,913.32 10.5595
WisdomTree Europe Equity UCITS ETF - USD Hedged 16/10/2018 IE00BVXBH163 3215375 USD 53,559,914.85 16.6574
WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 16/10/2018 IE00BYQCZP72 3413137 USD 64,084,134.40 18.7757
WisdomTree Europe Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJC527 3679859 EUR 59,868,625.12 16.2693
WisdomTree Europe Small Cap Dividend UCITS ETF Acc 16/10/2018 IE00BDF16114 771490 EUR 10,890,138.51 14.1157
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR 16/10/2018 IE00BZ56SY76 416881 EUR 5,927,752.32 14.2193
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 16/10/2018 IE00BZ56TQ67 938013 EUR 14,735,438.30 15.7092
WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZ914 45884 CHF 797,836.19 17.3881
WisdomTree Germany Equity UCITS ETF - EUR Acc 16/10/2018 IE00BYQCZC44 251123 EUR 3,886,059.62 15.4747
WisdomTree Germany Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BVXBGY20 507894 GBP 4,923,724.20 9.6944
WisdomTree Germany Equity UCITS ETF - USD Hedged 16/10/2018 IE00BYQCZ682 17536 USD 301,507.95 17.1937
WisdomTree Global Quality Dividend Growth UCITS ETF - USD 16/10/2018 IE00BZ56RN96 88688 USD 1,818,329.15 20.5025
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 16/10/2018 IE00BZ56SW52 430680 USD 9,167,031.35 21.285
WisdomTree India Quality UCITS ETF - USD 16/10/2018 IE00BDGSNK96 152500 USD 2,457,868.63 16.1172
WisdomTree India Quality UCITS ETF - USD Acc 16/10/2018 IE00BDGSNL04 222500 USD 3,594,009.49 16.1529
WisdomTree ISEQ 20 UCITS ETF 16/10/2018 IE00BVFB1H83 1300000 EUR 16,542,624.36 12.7251
WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZL35 202445 CHF 3,797,187.02 18.7566
WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 16/10/2018 IE00BYQCZJ13 664839 EUR 10,723,961.93 16.1302
WisdomTree Japan Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BYQCZF74 146865 GBP 1,587,648.25 10.8103
WisdomTree Japan Equity UCITS ETF - JPY Acc 16/10/2018 IE00BYQCZN58 2333721 USD 45,052,234.24 19.3049
WisdomTree Japan Equity UCITS ETF - USD Hedged 16/10/2018 IE00BVXC4854 9668036 USD 157,270,221.13 16.267
WisdomTree Japan Equity UCITS ETF - USD Hedged Acc 16/10/2018 IE00BYQCZD50 736932 USD 13,054,257.72 17.7143
WisdomTree Japan SmallCap Dividend UCITS ETF - USD 16/10/2018 IE00BFXYK923 20000 USD 962,280.91 48.114
WisdomTree Japan SmallCap Dividend UCITS ETF - USD Acc 16/10/2018 IE00BFXYKD63 20000 USD 962,280.93 48.114
WisdomTree UK Equity Income UCITS ETF 16/10/2018 IE00BYPGTJ26 840000 GBP 4,421,698.95 5.2639
WisdomTree US Equity Income UCITS ETF 16/10/2018 IE00BQZJBQ63 1502087 USD 28,781,238.48 19.1608
WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc 16/10/2018 IE00BD6RZW23 24773 EUR 406,812.14 16.4216
WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 16/10/2018 IE00BD6RZZ53 155031 GBP 2,285,629.49 14.743
WisdomTree US Equity Income UCITS ETF Acc 16/10/2018 IE00BD6RZT93 223095 USD 4,209,843.03 18.8702
WisdomTree US Multifactor UCITS ETF – USD 16/10/2018 IE00BD8ZCY59 10000 USD 501,361.44 50.1361
WisdomTree US Multifactor UCITS ETF – USD Acc 16/10/2018 IE00BD8ZD313 10000 USD 501,361.36 50.1361
WisdomTree US Quality Dividend Growth UCITS ETF - USD 16/10/2018 IE00BZ56RD98 42491 USD 931,975.65 21.9335
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 16/10/2018 IE00BZ56RG20 687537 USD 15,578,588.14 22.6585
WisdomTree US Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJBT94 650000 USD 13,072,570.88 20.1116 Reported by GlobeNewswire 32 minutes ago.
* * * *
WisdomTree AT1 CoCo Bond UCITS ETF – USD 16/10/2018 IE00BZ0XVF52 328045 USD 31,399,731.42 95.7178
WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 16/10/2018 IE00BFNNN236 20828 EUR 2,065,997.95 99.1933
WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 16/10/2018 IE00BFNNN459 20740 GBP 2,062,429.16 99.4421
WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc 16/10/2018 IE00BZ0XVG69 9000 USD 865,297.71 96.1442
WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged 16/10/2018 IE00BFNNN012 20962 USD 2,088,813.17 99.6476
WisdomTree CBOE S&P 500 PutWrite UCITS ETF - USD Acc 16/10/2018 IE00BD49R243 1680000 USD 84,929,384.73 50.5532
WisdomTree Emerging Asia Equity Income UCITS ETF 16/10/2018 IE00BYPGT035 1125000 USD 11,938,197.77 10.6117
WisdomTree Emerging Markets Equity Income UCITS ETF 16/10/2018 IE00BQQ3Q067 2042097 USD 30,613,416.43 14.9912
WisdomTree Emerging Markets Equity Income UCITS ETF Acc 16/10/2018 IE00BDF12W49 108242 USD 2,050,911.98 18.9475
WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJBM26 1375000 USD 21,818,183.67 15.8678
WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc 16/10/2018 IE00BG88WG77 25000 EUR 257,205.71 10.2882
WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc 16/10/2018 IE00BG88WH84 1325000 GBP 13,657,621.72 10.3076
WisdomTree Enhanced Commodity UCITS ETF - USD 16/10/2018 IE00BZ1GHD37 525000 USD 5,689,709.19 10.8375
WisdomTree Enhanced Commodity UCITS ETF - USD Acc 16/10/2018 IE00BYMLZY74 12450000 USD 135,522,711.02 10.8854
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR 16/10/2018 IE00BD49R912 30000 EUR 1,478,620.50 49.2874
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc 16/10/2018 IE00BD49RB39 30000 EUR 1,478,621.48 49.2874
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF 16/10/2018 IE00BD49RJ15 30000 EUR 1,464,658.87 48.822
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc 16/10/2018 IE00BD49RK20 30000 EUR 1,464,659.24 48.822
WisdomTree Europe Equity Income UCITS ETF 16/10/2018 IE00BQZJBX31 3548600 EUR 44,743,899.80 12.6089
WisdomTree Europe Equity Income UCITS ETF Acc 16/10/2018 IE00BDF16007 40010 EUR 576,074.23 14.3983
WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZT11 17096 CHF 270,930.89 15.8476
WisdomTree Europe Equity UCITS ETF - EUR Acc 16/10/2018 IE00BYQCZX56 1304306 EUR 20,982,916.82 16.0874
WisdomTree Europe Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BYQCZQ89 372454 GBP 3,932,913.32 10.5595
WisdomTree Europe Equity UCITS ETF - USD Hedged 16/10/2018 IE00BVXBH163 3215375 USD 53,559,914.85 16.6574
WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 16/10/2018 IE00BYQCZP72 3413137 USD 64,084,134.40 18.7757
WisdomTree Europe Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJC527 3679859 EUR 59,868,625.12 16.2693
WisdomTree Europe Small Cap Dividend UCITS ETF Acc 16/10/2018 IE00BDF16114 771490 EUR 10,890,138.51 14.1157
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR 16/10/2018 IE00BZ56SY76 416881 EUR 5,927,752.32 14.2193
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 16/10/2018 IE00BZ56TQ67 938013 EUR 14,735,438.30 15.7092
WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZ914 45884 CHF 797,836.19 17.3881
WisdomTree Germany Equity UCITS ETF - EUR Acc 16/10/2018 IE00BYQCZC44 251123 EUR 3,886,059.62 15.4747
WisdomTree Germany Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BVXBGY20 507894 GBP 4,923,724.20 9.6944
WisdomTree Germany Equity UCITS ETF - USD Hedged 16/10/2018 IE00BYQCZ682 17536 USD 301,507.95 17.1937
WisdomTree Global Quality Dividend Growth UCITS ETF - USD 16/10/2018 IE00BZ56RN96 88688 USD 1,818,329.15 20.5025
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 16/10/2018 IE00BZ56SW52 430680 USD 9,167,031.35 21.285
WisdomTree India Quality UCITS ETF - USD 16/10/2018 IE00BDGSNK96 152500 USD 2,457,868.63 16.1172
WisdomTree India Quality UCITS ETF - USD Acc 16/10/2018 IE00BDGSNL04 222500 USD 3,594,009.49 16.1529
WisdomTree ISEQ 20 UCITS ETF 16/10/2018 IE00BVFB1H83 1300000 EUR 16,542,624.36 12.7251
WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 16/10/2018 IE00BYQCZL35 202445 CHF 3,797,187.02 18.7566
WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 16/10/2018 IE00BYQCZJ13 664839 EUR 10,723,961.93 16.1302
WisdomTree Japan Equity UCITS ETF - GBP Hedged 16/10/2018 IE00BYQCZF74 146865 GBP 1,587,648.25 10.8103
WisdomTree Japan Equity UCITS ETF - JPY Acc 16/10/2018 IE00BYQCZN58 2333721 USD 45,052,234.24 19.3049
WisdomTree Japan Equity UCITS ETF - USD Hedged 16/10/2018 IE00BVXC4854 9668036 USD 157,270,221.13 16.267
WisdomTree Japan Equity UCITS ETF - USD Hedged Acc 16/10/2018 IE00BYQCZD50 736932 USD 13,054,257.72 17.7143
WisdomTree Japan SmallCap Dividend UCITS ETF - USD 16/10/2018 IE00BFXYK923 20000 USD 962,280.91 48.114
WisdomTree Japan SmallCap Dividend UCITS ETF - USD Acc 16/10/2018 IE00BFXYKD63 20000 USD 962,280.93 48.114
WisdomTree UK Equity Income UCITS ETF 16/10/2018 IE00BYPGTJ26 840000 GBP 4,421,698.95 5.2639
WisdomTree US Equity Income UCITS ETF 16/10/2018 IE00BQZJBQ63 1502087 USD 28,781,238.48 19.1608
WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc 16/10/2018 IE00BD6RZW23 24773 EUR 406,812.14 16.4216
WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 16/10/2018 IE00BD6RZZ53 155031 GBP 2,285,629.49 14.743
WisdomTree US Equity Income UCITS ETF Acc 16/10/2018 IE00BD6RZT93 223095 USD 4,209,843.03 18.8702
WisdomTree US Multifactor UCITS ETF – USD 16/10/2018 IE00BD8ZCY59 10000 USD 501,361.44 50.1361
WisdomTree US Multifactor UCITS ETF – USD Acc 16/10/2018 IE00BD8ZD313 10000 USD 501,361.36 50.1361
WisdomTree US Quality Dividend Growth UCITS ETF - USD 16/10/2018 IE00BZ56RD98 42491 USD 931,975.65 21.9335
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 16/10/2018 IE00BZ56RG20 687537 USD 15,578,588.14 22.6585
WisdomTree US Small Cap Dividend UCITS ETF 16/10/2018 IE00BQZJBT94 650000 USD 13,072,570.88 20.1116 Reported by GlobeNewswire 32 minutes ago.
↧
Europe’s clean transport revolution continues
There is now a clear EU majority, led by the Nordic countries, for tougher targets on car emissions, writes Sanjeev Kumar. The big questions now relates to charging points for electric vehicles and whether they can charge fast enough, he writes.
Reported by EurActiv 33 minutes ago.
↧
Altair Acquires SIMSOLID
*Game-Changing Simulation Technology for Designers, Design Engineers, and Simulation Analysts*
TROY, Mich., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR) has acquired SIMSOLID, a company founded by asking a simple question: “Why does the geometry used in the Design and Structural Simulation worlds have to be so different?”
SIMSOLID works on full-fidelity CAD assemblies to provide fast, accurate, and robust structural simulation without requiring geometry simplification, cleanup, or meshing. Its underlying technology is based largely on the work of Dr. Victor Apanovitch, a former professor at Belarus Polytechnic University and the cofounder of SIMSOLID Corporation.
“We believe SIMSOLID is a revolutionary technological breakthrough which will have a profound impact for product design,” said James Scapa, Altair’s Founder, Chairman, and CEO, “It’s incredibly fast, accurate, and robust and we believe a game changer for our industry.”
The SIMSOLID computational engine is a commercial implementation of novel and unpublished mathematics based on extensions to the theory of external approximations. SIMSOLID controls solution accuracy using multi-pass adaptive analysis, making it extremely fast and memory efficient. Large and complex assemblies can be solved rapidly even on laptop computers.
Dr. Uwe Schramm, Altair’s Chief Technical Officer, notes that, “We are very serious about solution accuracy. Others have tried to accelerate the interface between CAD and simulation by degrading the mathematical robustness. It is our feeling that by rapidly moving forward with the methods in SIMSOLID and expanding them across applications we can have a real effect on how design gets done while maintaining our high standards for computational excellence.”
To learn more about SIMSOLID, hear executives and technologists discuss more in this video, and register for an upcoming introductory SIMSOLID webinar or contact a regional representative at www.altair.com/SIMSOLID.
*About Altair (Nasdaq: ALTR)*
Altair transforms design and decision making by applying simulation, machine learning and optimization throughout product lifecycles. Our broad portfolio of simulation technology and patented units-based software licensing model enable Simulation-Driven Innovation™ for our customers. With more than 2,000 employees, Altair is headquartered in Troy, Michigan, USA and operates 71 offices throughout 24 countries. Altair serves more than 5,000 customers across broad industry segments. To learn more, please visit www.altair.com.
*Cautionary Language Concerning Forward-Looking Statements*
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our business outlook, potential growth, market positioning and future investments, and our reconciliations of projected non-GAAP financial measures. These forward-looking statements are made as of the date of this release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Altair’s control. Altair’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in Altair’s quarterly and annual reports filed with the Securities and Exchange Commission as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. Past performance is not necessarily indicative of future results. The forward-looking statements included in this press release represent Altair’s views as of the date of this press release. The Company anticipates that subsequent events and developments will cause its views to change. Altair undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Altair’s views as of any date subsequent to the date of this press release.
*Media Contacts Altair:*
Corporate / Americas/ Asia Pacific
Biba A. Bedi
+1.248.614.2400 x 392
biba@altair.com
Altair Europe/ The Middle East/Africa
Evelyn Gebhardt
+49 6421 9684351
gebhardt@bluegecko-marketing.de
Reported by GlobeNewswire 12 minutes ago.
TROY, Mich., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Altair (Nasdaq: ALTR) has acquired SIMSOLID, a company founded by asking a simple question: “Why does the geometry used in the Design and Structural Simulation worlds have to be so different?”
SIMSOLID works on full-fidelity CAD assemblies to provide fast, accurate, and robust structural simulation without requiring geometry simplification, cleanup, or meshing. Its underlying technology is based largely on the work of Dr. Victor Apanovitch, a former professor at Belarus Polytechnic University and the cofounder of SIMSOLID Corporation.
“We believe SIMSOLID is a revolutionary technological breakthrough which will have a profound impact for product design,” said James Scapa, Altair’s Founder, Chairman, and CEO, “It’s incredibly fast, accurate, and robust and we believe a game changer for our industry.”
The SIMSOLID computational engine is a commercial implementation of novel and unpublished mathematics based on extensions to the theory of external approximations. SIMSOLID controls solution accuracy using multi-pass adaptive analysis, making it extremely fast and memory efficient. Large and complex assemblies can be solved rapidly even on laptop computers.
Dr. Uwe Schramm, Altair’s Chief Technical Officer, notes that, “We are very serious about solution accuracy. Others have tried to accelerate the interface between CAD and simulation by degrading the mathematical robustness. It is our feeling that by rapidly moving forward with the methods in SIMSOLID and expanding them across applications we can have a real effect on how design gets done while maintaining our high standards for computational excellence.”
To learn more about SIMSOLID, hear executives and technologists discuss more in this video, and register for an upcoming introductory SIMSOLID webinar or contact a regional representative at www.altair.com/SIMSOLID.
*About Altair (Nasdaq: ALTR)*
Altair transforms design and decision making by applying simulation, machine learning and optimization throughout product lifecycles. Our broad portfolio of simulation technology and patented units-based software licensing model enable Simulation-Driven Innovation™ for our customers. With more than 2,000 employees, Altair is headquartered in Troy, Michigan, USA and operates 71 offices throughout 24 countries. Altair serves more than 5,000 customers across broad industry segments. To learn more, please visit www.altair.com.
*Cautionary Language Concerning Forward-Looking Statements*
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our business outlook, potential growth, market positioning and future investments, and our reconciliations of projected non-GAAP financial measures. These forward-looking statements are made as of the date of this release and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Altair’s control. Altair’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in Altair’s quarterly and annual reports filed with the Securities and Exchange Commission as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. Past performance is not necessarily indicative of future results. The forward-looking statements included in this press release represent Altair’s views as of the date of this press release. The Company anticipates that subsequent events and developments will cause its views to change. Altair undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Altair’s views as of any date subsequent to the date of this press release.
*Media Contacts Altair:*
Corporate / Americas/ Asia Pacific
Biba A. Bedi
+1.248.614.2400 x 392
biba@altair.com
Altair Europe/ The Middle East/Africa
Evelyn Gebhardt
+49 6421 9684351
gebhardt@bluegecko-marketing.de
Reported by GlobeNewswire 12 minutes ago.
↧
Aya Nakamura Is A Viral Sensation
Check out her European smash 'Djadja'...
*Aya Nakamura* seems to have that golden touch.
The French artist matches afrobeats to R&B, hip-hop to pop, producing something that is completely accessible, totally addictive, and yet still has that underground flavour.
Her breakout single 'Djadja' has already conquered Europe, an infectious, sensual jammer that places her vocal right to the fore.
The original track is in French, and has earned a place in the history books by becoming the first French language track to hit the top spot on the Dutch chart.
Afro B has stepped in to give 'Djadja' a UK-centric remix, and it's already causing a stir with its sheer unrelenting energy.
So, could Aya Nakamura make a dent on British shores? We wouldn't bet against it...
Tune in now.
Join us on *Vero*, as we get under the skin of global cultural happenings. Follow *Clash Magazine* as we skip merrily between clubs, concerts, interviews and photo shoots. Get backstage sneak peeks and a true view into our world as the fun and games unfold.
***B*uy Clash Magazine** Reported by Clash 14 minutes ago.
*Aya Nakamura* seems to have that golden touch.
The French artist matches afrobeats to R&B, hip-hop to pop, producing something that is completely accessible, totally addictive, and yet still has that underground flavour.
Her breakout single 'Djadja' has already conquered Europe, an infectious, sensual jammer that places her vocal right to the fore.
The original track is in French, and has earned a place in the history books by becoming the first French language track to hit the top spot on the Dutch chart.
Afro B has stepped in to give 'Djadja' a UK-centric remix, and it's already causing a stir with its sheer unrelenting energy.
So, could Aya Nakamura make a dent on British shores? We wouldn't bet against it...
Tune in now.
Join us on *Vero*, as we get under the skin of global cultural happenings. Follow *Clash Magazine* as we skip merrily between clubs, concerts, interviews and photo shoots. Get backstage sneak peeks and a true view into our world as the fun and games unfold.
***B*uy Clash Magazine** Reported by Clash 14 minutes ago.
↧
↧
Global Stocks Extend Rebound
Stocks in Asia and Europe advanced after a rally in the U.S. in which the Dow rose more than 500 points. Futures pointed to a small opening gain for U.S. stocks.
Reported by Wall Street Journal 5 minutes ago.
↧
Atos and Siemens team up to enable enterprises to deploy IoT applications on private Cloud
*Businesses now have flexibility to host applications on private as well as public Cloud*
*Paris, Munich, October 17, 2018 *- Atos, a global leader in digital transformation and Siemens, a global technology powerhouse, today announce that they now deliver Private Cloud options for the MindSphere Cloud-based IoT Operating System, with the ambition to further accelerate their joint business cooperation in Digital Services and Digital technologies. Selected customers are now able to experience the solution on Microsoft Azure Stack.
The two companies agreed on a preferred partnership for the provision of the solution which fully leverages Microsoft Azure Stack technology as the Private Cloud platform. Microsoft Azure Stack is a solution which allows enterprises to benefit from a private instance of the Microsoft Azure cloud. Atos provides Microsoft Azure Stack as part of Atos' wide set of hybrid Cloud solutions to transform infrastructures and applications.
The private Cloud instance of MindSphere will provide the following benefits:
· *Data compliance*, paramount to sensitive and regulated industries. Atos will run MindSphere in the Atos and Atos customer's datacenters, located in Europe and fully managed according to industry standard Service Level Agreements - making sure enterprise data and connectivity are well managed in accordance to local regulations
· *Enhanced application performance and landscape integration* - with reduced latencies between the MindSphere environment and associated enterprise applications
More generally, MindSphere offers:
· *Support for a wide range of devices, industry-specific applications and protocols* - and advanced analytics
· *Innovative development environment* based on Siemens' open Platform-as-a-Service (PaaS) capabilities
*Dr. Jan Mrosik, Siemens AG, CEO Digital Factory Division* explains: "With this solution, enterprise customers get the best of the three worlds to drive their digital transformation with us: it links the global portfolio of the leading solutions of Siemens Digital Factory with Atos IoT-driven integration, infrastructure, consulting and security services for MindSphere and Microsoft Azure Stack technology. Thanks to the preferred service agreement with Atos, once again we intensify our collaboration and will be able to further support our customers in developing robust industrial IoT solutions on a shorter timeline across various industries."*Gilles Grapinet, Atos Senior Executive Vice President *adds: "Together with Siemens, we are taking MindSphere to the next level - thanks to Microsoft Azure Stack technology - by allowing customers to deploy digital-driven business applications in a secure, managed private Cloud infrastructure - thus making sure they get the best Siemens MindSphere experience."
By offering on-premise services, Atos will manage all aspects of cloud infrastructure and delivery, scaling up as business needs change and ensuring performance, security and clarity of reporting at all times.
To find out more about MindSphere, visit our website here.
Siemens MindSphere is a key platform component within Atos Codex, Atos' suite of IoT, analytics and AI solutions and services. As a strategic partner to Siemens, Atos has been one of the first partners to enter the MindSphere ecosystem by developing an approach to Manufacturing IoT exploitation which balances innovation and compliance in equal measure - and most importantly which delivers quantifiable benefit rapidly and reliably. In particular, Atos offers MindSphere customers a structured approach; from quick-start services with first real results to production readiness of MindSphere applications, in order to accelerate the prototyping, validation and deployment of MindSphere applications through automated and predefined use cases.
***
*About Atos
*Atos is a global leader in digital transformation with 120,000 employees in 73 countries and annual revenue of € 13 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions through its Digital Transformation Factory, as well as transactional services through Worldline, the European leader in the payment industry. With its cutting-edge technologies and industry knowledge, Atos supports the digital transformation of its clients across all business sectors. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos Syntel, Unify and Worldline. Atos is listed on the CAC40 Paris stock index.
*About Siemens *
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment - such as computed tomography and magnetic resonance imaging systems - and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide.
Read more About Siemens
*Press contacts:*
Atos: Lucie Duchateau | +33 7 62 85 35 10 | lucie.duchateau@atos.net
*Attachment*
· Click here for the pdf version.pdf Reported by GlobeNewswire 2 minutes ago.
*Paris, Munich, October 17, 2018 *- Atos, a global leader in digital transformation and Siemens, a global technology powerhouse, today announce that they now deliver Private Cloud options for the MindSphere Cloud-based IoT Operating System, with the ambition to further accelerate their joint business cooperation in Digital Services and Digital technologies. Selected customers are now able to experience the solution on Microsoft Azure Stack.
The two companies agreed on a preferred partnership for the provision of the solution which fully leverages Microsoft Azure Stack technology as the Private Cloud platform. Microsoft Azure Stack is a solution which allows enterprises to benefit from a private instance of the Microsoft Azure cloud. Atos provides Microsoft Azure Stack as part of Atos' wide set of hybrid Cloud solutions to transform infrastructures and applications.
The private Cloud instance of MindSphere will provide the following benefits:
· *Data compliance*, paramount to sensitive and regulated industries. Atos will run MindSphere in the Atos and Atos customer's datacenters, located in Europe and fully managed according to industry standard Service Level Agreements - making sure enterprise data and connectivity are well managed in accordance to local regulations
· *Enhanced application performance and landscape integration* - with reduced latencies between the MindSphere environment and associated enterprise applications
More generally, MindSphere offers:
· *Support for a wide range of devices, industry-specific applications and protocols* - and advanced analytics
· *Innovative development environment* based on Siemens' open Platform-as-a-Service (PaaS) capabilities
*Dr. Jan Mrosik, Siemens AG, CEO Digital Factory Division* explains: "With this solution, enterprise customers get the best of the three worlds to drive their digital transformation with us: it links the global portfolio of the leading solutions of Siemens Digital Factory with Atos IoT-driven integration, infrastructure, consulting and security services for MindSphere and Microsoft Azure Stack technology. Thanks to the preferred service agreement with Atos, once again we intensify our collaboration and will be able to further support our customers in developing robust industrial IoT solutions on a shorter timeline across various industries."*Gilles Grapinet, Atos Senior Executive Vice President *adds: "Together with Siemens, we are taking MindSphere to the next level - thanks to Microsoft Azure Stack technology - by allowing customers to deploy digital-driven business applications in a secure, managed private Cloud infrastructure - thus making sure they get the best Siemens MindSphere experience."
By offering on-premise services, Atos will manage all aspects of cloud infrastructure and delivery, scaling up as business needs change and ensuring performance, security and clarity of reporting at all times.
To find out more about MindSphere, visit our website here.
Siemens MindSphere is a key platform component within Atos Codex, Atos' suite of IoT, analytics and AI solutions and services. As a strategic partner to Siemens, Atos has been one of the first partners to enter the MindSphere ecosystem by developing an approach to Manufacturing IoT exploitation which balances innovation and compliance in equal measure - and most importantly which delivers quantifiable benefit rapidly and reliably. In particular, Atos offers MindSphere customers a structured approach; from quick-start services with first real results to production readiness of MindSphere applications, in order to accelerate the prototyping, validation and deployment of MindSphere applications through automated and predefined use cases.
***
*About Atos
*Atos is a global leader in digital transformation with 120,000 employees in 73 countries and annual revenue of € 13 billion. European number one in Cloud, Cybersecurity and High-Performance Computing, the Group provides end-to-end Orchestrated Hybrid Cloud, Big Data, Business Applications and Digital Workplace solutions through its Digital Transformation Factory, as well as transactional services through Worldline, the European leader in the payment industry. With its cutting-edge technologies and industry knowledge, Atos supports the digital transformation of its clients across all business sectors. The Group is the Worldwide Information Technology Partner for the Olympic & Paralympic Games and operates under the brands Atos, Atos Syntel, Unify and Worldline. Atos is listed on the CAC40 Paris stock index.
*About Siemens *
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. With its publicly listed subsidiary Siemens Healthineers AG, the company is also a leading provider of medical imaging equipment - such as computed tomography and magnetic resonance imaging systems - and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 377,000 employees worldwide.
Read more About Siemens
*Press contacts:*
Atos: Lucie Duchateau | +33 7 62 85 35 10 | lucie.duchateau@atos.net
*Attachment*
· Click here for the pdf version.pdf Reported by GlobeNewswire 2 minutes ago.
↧
MOGO FINANCE REPORTS UNAUDITED RESULTS FOR THE NINE MONTHS ENDING 30 SEPTEMBER 2018
Loan portfolio up by 38.8% with strong performance in mature markets, further optimization of financing costs
OPERATIONAL AND STRATEGIC HIGHLIGHTS
· Significant growth in core business with Group loans issued increasing by approx. 75.5% equalling around EUR 93 million (9M 2017: approx.: EUR 53 million), of which EUR 63 million issued in mature markets^^[1] (9M 2017: EUR 43 million).
· Consolidated number of active customers up significantly by approx. 40.9% to over 62,000 (31 December 2017: approx. 44,000).
· Launch of operations in Albania, Belarus and Ukraine, steady growth in countries launched in 2017 – Bulgaria, Romania, and Moldova – with loan demand for the most part exceeding expectations.
· Operations in Armenia acquired with consolidation as of August 2018 already profitable on a monthly basis.
· Successful internal regional restructuring completed to deliver future focus, business and cost efficiencies.
· Improved management efficiencies by separating car sales management from financing activities.
FINANCIAL HIGHLIGHTS AND PROGRESS
· Interest and similar income significantly above previous year’s period 54.4% to EUR 41.7 million (9M 2017: EUR 27.0 million).
· Harmonized EBITDA improved by 9.2% to EUR 16.6million (9M 2017: EUR 15.2 million) with significant contribution from mature countries with harmonized EBITDA of EUR 20.1 million (9M 2017: EUR 15.1 million).
· Optimization of financing costs to 11.2% in Q3 2018 (6M 2018: 12.3%).
· Stable loan portfolio quality – NPL 14.5% (35+DPD) of gross portfolio with provision coverage ratio of 88.4%.
· Slight increase in overall cost to income ratio to 32.4% (9M 2017: 28.1%) impacted by new country launches and completed internal restructuring, mitigated partially by improved economies of scale in mature countries with cost to income ratio decreasing to 22.4% (9M 2017: 28.4%).
· Strong capitalization ratio improved to 12.2% (31 December 2017: 11.8%).
Edgars Egle, CEO of Mogo Finance, commented:
“These strong results with revenues up by 54.4%, improved capitalization ratio and decreased effective funding costs reflect the strong foundation of Mogo Finance Group. The results are mainly driven by our mature and profitable countries in Latvia, Lithuania, Estonia and Georgia, while we have made a good progress and base for future improvements in profitability for countries launched in 2017 and 2018.
Investments in our people, IT, risk management and new countries have delivered the foundation for future profitability. These investments were critical for building sustainable and well-diversified business. We look forward to deliver our goals and continue to deliver best in class service to our customers."
The full unaudited report for the nine months ending 30 September 2018 is available here.
Conference Call:
A conference call in English with the Group's management team to discuss these results is scheduled for 23 October 2018, at 17:00 CEST.
Please register here.
The presentation for the conference call will be available here as of 23 October 2018, at 9:00 CEST.
Contact:
Mogo Finance (CFO), Email: *maris.kreics@mogofinance.com*
Maris Kreics +371 66 900 900
Aalto Capital, Email: *sven.pauly@aaltocapital.com*
Sven Pauly +49 89 8986777 0
About Mogo Finance:
Mogo Finance is one of the largest and fastest growing secured used car financing companies in Europe. Recognizing the niche in used car financing underserved by traditional lenders, Mogo Finance has expanded its operations to 12 countries issuing over EUR 320 million up to date and running a net loan portfolio over EUR 130 million. Mogo offers secured loans up to EUR 15,000 with maximum tenor of 84 months making used car financing process convenient, both for its customers and partners. Wide geographical presence makes Mogo unique over its rivals and diversifies revenue streams.
Mogo Finance operates through its own branch network, more than 1,500 partner locations and strong online presence. Physical footprint makes Mogo Finance top of mind brand in used car financing. Established in 2012, headquartered in Riga, Latvia and operates in: Latvia, Estonia, Lithuania, Georgia, Poland, Romania, Bulgaria, Moldova, Albania, Belarus, Armenia and Ukraine.
www.mogofinance.com IMPORTANT INFORMATION
The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Persons into whose possession this announcement may come are required to inform themselves of and observe all such restrictions.
This announcement does not constitute an offer of securities for sale in the United States. The bonds have not been and will not be registered under the Securities Act or under the applicable securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This announcement does not constitute a prospectus for the purposes of Directive 2003/71/EC, as amended (the "Prospectus Directive") and does not constitute a public offer of securities in any member state of the European Economic Area (the "EEA").
This announcement does not constitute an offer of bonds to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the bonds. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this announcement as a financial promotion may only be distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or any of its contents.
PROFESSIONAL INVESTORS ONLY – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the bonds do not constitute packaged products and will be offered to eligible counterparties and professional clients only.
[1] Mature markets are Latvia, Lithuania, Estonia and Georgia
Reported by GlobeNewswire 2 hours ago.
OPERATIONAL AND STRATEGIC HIGHLIGHTS
· Significant growth in core business with Group loans issued increasing by approx. 75.5% equalling around EUR 93 million (9M 2017: approx.: EUR 53 million), of which EUR 63 million issued in mature markets^^[1] (9M 2017: EUR 43 million).
· Consolidated number of active customers up significantly by approx. 40.9% to over 62,000 (31 December 2017: approx. 44,000).
· Launch of operations in Albania, Belarus and Ukraine, steady growth in countries launched in 2017 – Bulgaria, Romania, and Moldova – with loan demand for the most part exceeding expectations.
· Operations in Armenia acquired with consolidation as of August 2018 already profitable on a monthly basis.
· Successful internal regional restructuring completed to deliver future focus, business and cost efficiencies.
· Improved management efficiencies by separating car sales management from financing activities.
FINANCIAL HIGHLIGHTS AND PROGRESS
· Interest and similar income significantly above previous year’s period 54.4% to EUR 41.7 million (9M 2017: EUR 27.0 million).
· Harmonized EBITDA improved by 9.2% to EUR 16.6million (9M 2017: EUR 15.2 million) with significant contribution from mature countries with harmonized EBITDA of EUR 20.1 million (9M 2017: EUR 15.1 million).
· Optimization of financing costs to 11.2% in Q3 2018 (6M 2018: 12.3%).
· Stable loan portfolio quality – NPL 14.5% (35+DPD) of gross portfolio with provision coverage ratio of 88.4%.
· Slight increase in overall cost to income ratio to 32.4% (9M 2017: 28.1%) impacted by new country launches and completed internal restructuring, mitigated partially by improved economies of scale in mature countries with cost to income ratio decreasing to 22.4% (9M 2017: 28.4%).
· Strong capitalization ratio improved to 12.2% (31 December 2017: 11.8%).
Edgars Egle, CEO of Mogo Finance, commented:
“These strong results with revenues up by 54.4%, improved capitalization ratio and decreased effective funding costs reflect the strong foundation of Mogo Finance Group. The results are mainly driven by our mature and profitable countries in Latvia, Lithuania, Estonia and Georgia, while we have made a good progress and base for future improvements in profitability for countries launched in 2017 and 2018.
Investments in our people, IT, risk management and new countries have delivered the foundation for future profitability. These investments were critical for building sustainable and well-diversified business. We look forward to deliver our goals and continue to deliver best in class service to our customers."
The full unaudited report for the nine months ending 30 September 2018 is available here.
Conference Call:
A conference call in English with the Group's management team to discuss these results is scheduled for 23 October 2018, at 17:00 CEST.
Please register here.
The presentation for the conference call will be available here as of 23 October 2018, at 9:00 CEST.
Contact:
Mogo Finance (CFO), Email: *maris.kreics@mogofinance.com*
Maris Kreics +371 66 900 900
Aalto Capital, Email: *sven.pauly@aaltocapital.com*
Sven Pauly +49 89 8986777 0
About Mogo Finance:
Mogo Finance is one of the largest and fastest growing secured used car financing companies in Europe. Recognizing the niche in used car financing underserved by traditional lenders, Mogo Finance has expanded its operations to 12 countries issuing over EUR 320 million up to date and running a net loan portfolio over EUR 130 million. Mogo offers secured loans up to EUR 15,000 with maximum tenor of 84 months making used car financing process convenient, both for its customers and partners. Wide geographical presence makes Mogo unique over its rivals and diversifies revenue streams.
Mogo Finance operates through its own branch network, more than 1,500 partner locations and strong online presence. Physical footprint makes Mogo Finance top of mind brand in used car financing. Established in 2012, headquartered in Riga, Latvia and operates in: Latvia, Estonia, Lithuania, Georgia, Poland, Romania, Bulgaria, Moldova, Albania, Belarus, Armenia and Ukraine.
www.mogofinance.com IMPORTANT INFORMATION
The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Persons into whose possession this announcement may come are required to inform themselves of and observe all such restrictions.
This announcement does not constitute an offer of securities for sale in the United States. The bonds have not been and will not be registered under the Securities Act or under the applicable securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This announcement does not constitute a prospectus for the purposes of Directive 2003/71/EC, as amended (the "Prospectus Directive") and does not constitute a public offer of securities in any member state of the European Economic Area (the "EEA").
This announcement does not constitute an offer of bonds to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the bonds. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this announcement as a financial promotion may only be distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or any of its contents.
PROFESSIONAL INVESTORS ONLY – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the bonds do not constitute packaged products and will be offered to eligible counterparties and professional clients only.
[1] Mature markets are Latvia, Lithuania, Estonia and Georgia
Reported by GlobeNewswire 2 hours ago.
↧
Mogo Finance reports unaudited results for the nine months ending 30 September 2018
DGAP-News: Mogo Finance S.A. / Key word(s): 9-month figures
18.10.2018 / 09:15
The issuer is solely responsible for the content of this announcement.
--------------------
*Mogo Finance reports unaudited results for the nine months ending 30 September 2018*Loan portfolio up by 38.8% with strong performance in mature markets, further optimization of financing costs*OPERATIONAL AND STRATEGIC HIGHLIGHTS*
- Significant growth in core business with Group loans issued increasing by approx. 75.5% equalling around EUR 93 million (9M 2017: approx.: EUR 53 million), of which EUR 63 million issued in mature markets^[1] (9M 2017: EUR 43 million).
- Consolidated number of active customers up significantly by approx. 40.9% to over 62,000 (31 December 2017: approx. 44,000).
- Launch of operations in Albania, Belarus and Ukraine, steady growth in countries launched in 2017 - Bulgaria, Romania, and Moldova - with loan demand for the most part exceeding expectations.
- Operations in Armenia acquired with consolidation as of August 2018 already profitable on a monthly basis.
- Successful internal regional restructuring completed to deliver future focus, business and cost efficiencies.
- Improved management efficiencies by separating car sales management from financing activities.*FINANCIAL HIGHLIGHTS AND PROGRESS*
- Interest and similar income significantly above previous year's period 54.4% to EUR 41.7 million (9M 2017: EUR 27.0 million).
- Harmonized EBITDA improved by 9.2% to EUR 16.6million (9M 2017: EUR 15.2 million) with significant contribution from mature countries with harmonized EBITDA of EUR 20.1 million (9M 2017: EUR 15.1 million).
- Optimization of financing costs to 11.2% in Q3 2018 (6M 2018: 12.3%).
- Stable loan portfolio quality - NPL 14.5% (35+DPD) of gross portfolio with provision coverage ratio of 88.4%.
- Slight increase in overall cost to income ratio to 32.4% (9M 2017: 28.1%) impacted by new country launches and completed internal restructuring, mitigated partially by improved economies of scale in mature countries with cost to income ratio decreasing to 22.4% (9M 2017: 28.4%).
- Strong capitalization ratio improved to 12.2% (31 December 2017: 11.8%).
^[1] Mature markets are Latvia, Lithuania, Estonia and GeorgiaEdgars Egle, CEO of Mogo Finance, commented:
"These strong results with revenues up by 54.4%, improved capitalization ratio and decreased effective funding costs reflect the strong foundation of Mogo Finance Group. The results are mainly driven by our mature and profitable countries in Latvia, Lithuania, Estonia and Georgia, while we have made a good progress and base for future improvements in profitability for countries launched in 2017 and 2018.
Investments in our people, IT, risk management and new countries have delivered the foundation for future profitability. These investments were critical for building sustainable and well-diversified business. We look forward to deliver our goals and continue to deliver best in class service to our customers."
The full unaudited report for the nine months ending 30 September 2018 is available here.
*Conference Call:*
A conference call in English with the Group's management team to discuss these results is scheduled for 23 October 2018, at 17:00 CEST.
Please register here.
The presentation for the conference call will be available here as of 23 October 2018, at 9:00 CEST.
*Contact:*
Mogo Finance (CFO), Email: *maris.kreics@mogofinance.com*
Maris Kreics +371 66 900 900
Aalto Capital, Email: *sven.pauly@aaltocapital.com*
Sven Pauly +49 89 8986777 0
*About Mogo Finance:*
Mogo Finance is one of the largest and fastest growing secured used car financing companies in Europe. Recognizing the niche in used car financing underserved by traditional lenders, Mogo Finance has expanded its operations to 12 countries issuing over EUR 320 million up to date and running a net loan portfolio over EUR 130 million. Mogo offers secured loans up to EUR 15,000 with maximum tenor of 84 months making used car financing process convenient, both for its customers and partners. Wide geographical presence makes Mogo unique over its rivals and diversifies revenue streams.
Mogo Finance operates through its own branch network, more than 1,500 partner locations and strong online presence. Physical footprint makes Mogo Finance top of mind brand in used car financing. Established in 2012, headquartered in Riga, Latvia and operates in: Latvia, Estonia, Lithuania, Georgia, Poland, Romania, Bulgaria, Moldova, Albania, Belarus, Armenia and Ukraine.
www.mogofinance.com*IMPORTANT INFORMATION*
The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Persons into whose possession this announcement may come are required to inform themselves of and observe all such restrictions.
This announcement does not constitute an offer of securities for sale in the United States. The bonds have not been and will not be registered under the Securities Act or under the applicable securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This announcement does not constitute a prospectus for the purposes of Directive 2003/71/EC, as amended (the "Prospectus Directive") and does not constitute a public offer of securities in any member state of the European Economic Area (the "EEA").
This announcement does not constitute an offer of bonds to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the bonds. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this announcement as a financial promotion may only be distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or any of its contents.
PROFESSIONAL INVESTORS ONLY - Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the bonds do not constitute packaged products and will be offered to eligible counterparties and professional clients only.
--------------------
18.10.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de --------------------
Language: English
Company: Mogo Finance S.A.
Allee Scheffer
2520 Luxembourg
Luxemburg
Internet: www.mogofinance.com
ISIN: XS1831877755, LV0000801363
Listed: Regulated Unofficial Market in Frankfurt
End of News DGAP News Service Reported by EQS Group 2 hours ago.
18.10.2018 / 09:15
The issuer is solely responsible for the content of this announcement.
--------------------
*Mogo Finance reports unaudited results for the nine months ending 30 September 2018*Loan portfolio up by 38.8% with strong performance in mature markets, further optimization of financing costs*OPERATIONAL AND STRATEGIC HIGHLIGHTS*
- Significant growth in core business with Group loans issued increasing by approx. 75.5% equalling around EUR 93 million (9M 2017: approx.: EUR 53 million), of which EUR 63 million issued in mature markets^[1] (9M 2017: EUR 43 million).
- Consolidated number of active customers up significantly by approx. 40.9% to over 62,000 (31 December 2017: approx. 44,000).
- Launch of operations in Albania, Belarus and Ukraine, steady growth in countries launched in 2017 - Bulgaria, Romania, and Moldova - with loan demand for the most part exceeding expectations.
- Operations in Armenia acquired with consolidation as of August 2018 already profitable on a monthly basis.
- Successful internal regional restructuring completed to deliver future focus, business and cost efficiencies.
- Improved management efficiencies by separating car sales management from financing activities.*FINANCIAL HIGHLIGHTS AND PROGRESS*
- Interest and similar income significantly above previous year's period 54.4% to EUR 41.7 million (9M 2017: EUR 27.0 million).
- Harmonized EBITDA improved by 9.2% to EUR 16.6million (9M 2017: EUR 15.2 million) with significant contribution from mature countries with harmonized EBITDA of EUR 20.1 million (9M 2017: EUR 15.1 million).
- Optimization of financing costs to 11.2% in Q3 2018 (6M 2018: 12.3%).
- Stable loan portfolio quality - NPL 14.5% (35+DPD) of gross portfolio with provision coverage ratio of 88.4%.
- Slight increase in overall cost to income ratio to 32.4% (9M 2017: 28.1%) impacted by new country launches and completed internal restructuring, mitigated partially by improved economies of scale in mature countries with cost to income ratio decreasing to 22.4% (9M 2017: 28.4%).
- Strong capitalization ratio improved to 12.2% (31 December 2017: 11.8%).
^[1] Mature markets are Latvia, Lithuania, Estonia and GeorgiaEdgars Egle, CEO of Mogo Finance, commented:
"These strong results with revenues up by 54.4%, improved capitalization ratio and decreased effective funding costs reflect the strong foundation of Mogo Finance Group. The results are mainly driven by our mature and profitable countries in Latvia, Lithuania, Estonia and Georgia, while we have made a good progress and base for future improvements in profitability for countries launched in 2017 and 2018.
Investments in our people, IT, risk management and new countries have delivered the foundation for future profitability. These investments were critical for building sustainable and well-diversified business. We look forward to deliver our goals and continue to deliver best in class service to our customers."
The full unaudited report for the nine months ending 30 September 2018 is available here.
*Conference Call:*
A conference call in English with the Group's management team to discuss these results is scheduled for 23 October 2018, at 17:00 CEST.
Please register here.
The presentation for the conference call will be available here as of 23 October 2018, at 9:00 CEST.
*Contact:*
Mogo Finance (CFO), Email: *maris.kreics@mogofinance.com*
Maris Kreics +371 66 900 900
Aalto Capital, Email: *sven.pauly@aaltocapital.com*
Sven Pauly +49 89 8986777 0
*About Mogo Finance:*
Mogo Finance is one of the largest and fastest growing secured used car financing companies in Europe. Recognizing the niche in used car financing underserved by traditional lenders, Mogo Finance has expanded its operations to 12 countries issuing over EUR 320 million up to date and running a net loan portfolio over EUR 130 million. Mogo offers secured loans up to EUR 15,000 with maximum tenor of 84 months making used car financing process convenient, both for its customers and partners. Wide geographical presence makes Mogo unique over its rivals and diversifies revenue streams.
Mogo Finance operates through its own branch network, more than 1,500 partner locations and strong online presence. Physical footprint makes Mogo Finance top of mind brand in used car financing. Established in 2012, headquartered in Riga, Latvia and operates in: Latvia, Estonia, Lithuania, Georgia, Poland, Romania, Bulgaria, Moldova, Albania, Belarus, Armenia and Ukraine.
www.mogofinance.com*IMPORTANT INFORMATION*
The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or any other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the bonds in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Persons into whose possession this announcement may come are required to inform themselves of and observe all such restrictions.
This announcement does not constitute an offer of securities for sale in the United States. The bonds have not been and will not be registered under the Securities Act or under the applicable securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This announcement does not constitute a prospectus for the purposes of Directive 2003/71/EC, as amended (the "Prospectus Directive") and does not constitute a public offer of securities in any member state of the European Economic Area (the "EEA").
This announcement does not constitute an offer of bonds to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the bonds. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. The communication of this announcement as a financial promotion may only be distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). Any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or any of its contents.
PROFESSIONAL INVESTORS ONLY - Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the bonds do not constitute packaged products and will be offered to eligible counterparties and professional clients only.
--------------------
18.10.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de --------------------
Language: English
Company: Mogo Finance S.A.
Allee Scheffer
2520 Luxembourg
Luxemburg
Internet: www.mogofinance.com
ISIN: XS1831877755, LV0000801363
Listed: Regulated Unofficial Market in Frankfurt
End of News DGAP News Service Reported by EQS Group 2 hours ago.
↧
↧
FTSE LIVE: Domino's Pizza delivers despite UK uncertainty; Unilever misses analyst sales forecasts
Domino's Pizza said UK sales rose 2.2 per cent in the last three months despite 'evident uncertainty among UK consumers, and hot weather across Europe'.
Reported by MailOnline 2 hours ago.
↧
Global Cord Blood Banking Industry Report 2018: Approximately 450 Companies Offering Cord Blood Banking Services Worldwide
Dublin, Oct. 18, 2018 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2018" report has been added to *ResearchAndMarkets.com's* offering.New themes are impacting the industry, including the pairing of stem cell storage services with genetic and genomic testing services, as well as reproductive health services. Cord blood banks are diversifying into new types of stem cell storage, including umbilical cord tissue storage, placental blood and tissue, amniotic fluid and tissue, and dental pulp.
Cord blood banks are also investigating means of becoming integrated therapeutic companies, with LifebankUSA becoming an asset of the augmented immunity and longevity company Celularity and Americord announcing in a press release that it intends to launch its first therapeutic product offering sometime in 2018.
With approximately 450 companies offering cord blood banking services worldwide, maturation of the market means that each company is fighting harder for market share.
*Cord Blood Industry Consolidation*
Growing numbers of investors are now entering the marketplace, with M&A activity accelerating in the U.S. and abroad. In the United States, AMAG Pharmaceuticals sold Cord Blood Registry (CBR) to GI partners for $530 million in June 2018.
AMAG had previously bought CBR for $700 million in 2015. GI Partners, a private equity investment firm, simultaneously acquired CBR and California Cryobank (CCB) to merge the companies into a single entity that will be the global leader in stem cell storage and reproductive tissue services.
Holding companies are also emerging as a global theme, allowing for increased operational efficiency and economy of scale. Cryoholdco has established itself as the market leader within Latin America. Created in 2015, Cryoholdco is a holding company that will control nearly 200,000 stem cell units by the end of 2018. It now owns six cord blood banks, as well as a dental stem cell storage company.
Globally, networks of cord blood banks are also commonplace, with Sanpower Group establishing dominance in Asia. Although Sanpower has been quiet about its operations, its website states:
In 2016, Sanpower Group and its subsidiary Nanjing Cenbest announced their participation in founding a foundation to buy CO. In the same year, Nanjing Cenbest also acquired Shandong Cord Blood Bank. As a result, Sanpower now holds 4 licenses out of only 7 issued provincial-level cord blood bank licenses in China. It has reserved over 900,000 cord blood samples at home, and the associated reserves amount to almost 1,200,000 when counting in the Cordlife reserves across Southeast Asian countries and regions.
This positions Sanpower Group and its subsidiary Nanjing Cenbest as the world's largest cord blood banking operator not only in China and Southeast Asia, but in the world.
The number of cord blood banks in Europe has dropped by approximately one-third over the past ten years, from approximately 150 to 100. The industry leaders in this market segment include FamiCord Group, who has executed a dozen M&A transactions, and Vita34, who has executed approximately a half dozen. Stemlab, the largest cord blood bank in Portugal, also executed three acquisition deals prior to being acquired by FamiCord in July 2018.
FamiCord is now the leading stem cell bank in Europe, controlling over 263,000 cord blood and tissue units among its network of banks and over 347,000 biological samples of all types. This places it among the leading cord blood banks worldwide.
Dozens of other cord blood industry acquisitions have also occurred worldwide, with the highest frequency occurring within the United States, Europe, and Latin America.
*Digital Competition for Cord Blood Banking Services*
Digital competition for cord blood has been growing increasingly competitive. The term cord blood has now become one of the 20 most expensive search terms on Google. Winning online traffic through Google AdWords for the search phrase Cord Blood now costs $45.87 in the United States.
The cost for acquiring traffic through Google AdWords for the phrase Cord Blood is $32.91 when all geographies are allowed.
Cord Blood Expansion Technologies
Because cord blood utilization is largely limited to use in pediatric patients, growing investment is flowing into ex vivo cord blood expansion technologies.
*Key strategies being explored for this purpose include:*
· Nicotinamide-mediated (NAM) expansion
· Notch ligand
· SR-1
· UM171
· PGE2
· Enforced fucosylation
*Currently, the following companies have ex vivo cord blood expansion products in Phase II clinical trials:*
· Gamida Cell Ltd
· Nohla Therapeutics
· Excellthera
Magenta Therapeutics has a Phase I trial underway for its cord blood expansion technology.
Growing numbers of investors are also entering the cord blood banking marketplace, led by groups such as GI Partners, ABS Capital Partners & HLM Management, KKR & Company, Bay City Capital, GTCR, LLC, Excalibur, and more.
*Global Cord Blood Banking Industry Dynamics*
In 2008, a Taiwanese company, HealthBanks Biotech Company Ltd. became the first company to offer cord tissue storage. It was not until July 2010 that the first private U.S. cord blood bank began offering the service (Cord Blood Registry). Since then, the trend of cord tissue storage has had a major impact on the cord blood banking industry, with many cord blood banks worldwide now offering the service.
In China, the government shocked the industry by announcing that only one cord blood bank would be allowed to operate within each province, and official government support, authorization, and permits would be required.
In Italy and France, it is illegal to privately store one's cord blood, which has fully eliminated the potential for a private market to exist within the region.
In Ecuador, the government is now creating the first public cord blood bank and has instituted laws such that private cord blood banks cannot approach women about private cord blood banking options during the first six months of pregnancy. This created a crisis for the private banks, and there are now only two remaining in Ecuador.
Most recently, India's Central Drugs Standard Control Organization (CDSCO) restricted commercial banking of stem cells from most biological materials, including cord tissue, placenta, and dental pulp stem cells, leaving only umbilical cord blood banking as permitted and licensed within the country.
While market factors can vary by geography, it is crucial to have a global understanding of the market. Research advances, clinical trial findings, and technology advances do not know international boundaries.
The cord blood market is global in nature and understanding dynamics limited to your region is not sufficient for making strategic, informed, and profitable decisions.
*Cord Blood Report Highlights*
This 265 page report includes:
· Market size determinations for cord blood and tissue storage, with projections to 2022
· Volumes of cord blood and cord tissue storage worldwide
· Rates of worldwide cord blood storage (units per year)
· Rates of cord blood utilization
· Trend rate data for umbilical cord blood grants, patents, and scientific publications
· Clinical trial analysis, including comparison of cord blood vs. cord tissue trials
· Current and future conditions treatable with cord blood
· Regulatory pathways affecting cord blood banking in major healthcare markets
· Digital marketing assessment and comparison of industry leaders
· Competitive environment analysis, including identification of market leaders
· Leading investors within the cord blood marketplace
· Medical opinions of cord blood banking
· Crucial trends and unmet market needs
· And more
*Companies Mentioned *· ABS Capital Partners & HLM Management
· AllCells
· AlphaCord
· AMAG Pharmaceuticals
· Americord
· Bay City Capital
· Biocell Center
· BioEden
· Biosafe
· CariCord
· CBR
· CBR and California Cryobank (CCB)
· Cell Care (Australia)
· Cesca Therapeutics
· China Cord Blood Corporation (CCBC)
· CorCell
· Cord Blood Registry (CBR)
· Cordlife
· Core23 BioBank
· Crioestaminal
· Cryo-Cell International
· Cryoholdco
· Cryolife
· CryoSave
· Dentcell
· Excalibur
· FamiCord Group
· FamilyCord
· Fate Therapeutics
· Future Health Biobank
· Gamida Cell Ltd.
· GeneCell International
· Genesis Bank
· GI Partners
· GTCR, LLC
· HealthBaby
· HealthBanks Biotech Company Ltd
· Human Longevity Inc.
· Insception Lifebank
· KKR & Company
· LifebankUSA
· LifeCell International
· Lonza
· MAZE
· MiracleCord
· Nanjing Cenbest
· Natera, Inc. (EverCordTM)
· National Cord Blood Program (NCBP)
· New England Cord Blood Bank
· Nohla Therapeutics
· Novartis
· PacifiCord
· PerkinElmer
· Pluristem Therapeutics
· Precious Cells Group (now in administration, along with Pharmacells Ltd.)
· PromoCells
· ReeLabs
· Sanpower Group
· Shandong Cord Blood Bank
· Stem Cell Cryobank
· STEMCELL Technologies
· StemCyte
· Stemlab
· Thermo Fisher Scientific
· Transcell Biologics Pvt Ltd,
· VAULT SC Inc.
· ViaCord
· Vita34For more information about this report visit https://www.researchandmarkets.com/research/hxdwp3/global_cord_blood?w=12
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells , Blood Banking Reported by GlobeNewswire 2 hours ago.
Cord blood banks are also investigating means of becoming integrated therapeutic companies, with LifebankUSA becoming an asset of the augmented immunity and longevity company Celularity and Americord announcing in a press release that it intends to launch its first therapeutic product offering sometime in 2018.
With approximately 450 companies offering cord blood banking services worldwide, maturation of the market means that each company is fighting harder for market share.
*Cord Blood Industry Consolidation*
Growing numbers of investors are now entering the marketplace, with M&A activity accelerating in the U.S. and abroad. In the United States, AMAG Pharmaceuticals sold Cord Blood Registry (CBR) to GI partners for $530 million in June 2018.
AMAG had previously bought CBR for $700 million in 2015. GI Partners, a private equity investment firm, simultaneously acquired CBR and California Cryobank (CCB) to merge the companies into a single entity that will be the global leader in stem cell storage and reproductive tissue services.
Holding companies are also emerging as a global theme, allowing for increased operational efficiency and economy of scale. Cryoholdco has established itself as the market leader within Latin America. Created in 2015, Cryoholdco is a holding company that will control nearly 200,000 stem cell units by the end of 2018. It now owns six cord blood banks, as well as a dental stem cell storage company.
Globally, networks of cord blood banks are also commonplace, with Sanpower Group establishing dominance in Asia. Although Sanpower has been quiet about its operations, its website states:
In 2016, Sanpower Group and its subsidiary Nanjing Cenbest announced their participation in founding a foundation to buy CO. In the same year, Nanjing Cenbest also acquired Shandong Cord Blood Bank. As a result, Sanpower now holds 4 licenses out of only 7 issued provincial-level cord blood bank licenses in China. It has reserved over 900,000 cord blood samples at home, and the associated reserves amount to almost 1,200,000 when counting in the Cordlife reserves across Southeast Asian countries and regions.
This positions Sanpower Group and its subsidiary Nanjing Cenbest as the world's largest cord blood banking operator not only in China and Southeast Asia, but in the world.
The number of cord blood banks in Europe has dropped by approximately one-third over the past ten years, from approximately 150 to 100. The industry leaders in this market segment include FamiCord Group, who has executed a dozen M&A transactions, and Vita34, who has executed approximately a half dozen. Stemlab, the largest cord blood bank in Portugal, also executed three acquisition deals prior to being acquired by FamiCord in July 2018.
FamiCord is now the leading stem cell bank in Europe, controlling over 263,000 cord blood and tissue units among its network of banks and over 347,000 biological samples of all types. This places it among the leading cord blood banks worldwide.
Dozens of other cord blood industry acquisitions have also occurred worldwide, with the highest frequency occurring within the United States, Europe, and Latin America.
*Digital Competition for Cord Blood Banking Services*
Digital competition for cord blood has been growing increasingly competitive. The term cord blood has now become one of the 20 most expensive search terms on Google. Winning online traffic through Google AdWords for the search phrase Cord Blood now costs $45.87 in the United States.
The cost for acquiring traffic through Google AdWords for the phrase Cord Blood is $32.91 when all geographies are allowed.
Cord Blood Expansion Technologies
Because cord blood utilization is largely limited to use in pediatric patients, growing investment is flowing into ex vivo cord blood expansion technologies.
*Key strategies being explored for this purpose include:*
· Nicotinamide-mediated (NAM) expansion
· Notch ligand
· SR-1
· UM171
· PGE2
· Enforced fucosylation
*Currently, the following companies have ex vivo cord blood expansion products in Phase II clinical trials:*
· Gamida Cell Ltd
· Nohla Therapeutics
· Excellthera
Magenta Therapeutics has a Phase I trial underway for its cord blood expansion technology.
Growing numbers of investors are also entering the cord blood banking marketplace, led by groups such as GI Partners, ABS Capital Partners & HLM Management, KKR & Company, Bay City Capital, GTCR, LLC, Excalibur, and more.
*Global Cord Blood Banking Industry Dynamics*
In 2008, a Taiwanese company, HealthBanks Biotech Company Ltd. became the first company to offer cord tissue storage. It was not until July 2010 that the first private U.S. cord blood bank began offering the service (Cord Blood Registry). Since then, the trend of cord tissue storage has had a major impact on the cord blood banking industry, with many cord blood banks worldwide now offering the service.
In China, the government shocked the industry by announcing that only one cord blood bank would be allowed to operate within each province, and official government support, authorization, and permits would be required.
In Italy and France, it is illegal to privately store one's cord blood, which has fully eliminated the potential for a private market to exist within the region.
In Ecuador, the government is now creating the first public cord blood bank and has instituted laws such that private cord blood banks cannot approach women about private cord blood banking options during the first six months of pregnancy. This created a crisis for the private banks, and there are now only two remaining in Ecuador.
Most recently, India's Central Drugs Standard Control Organization (CDSCO) restricted commercial banking of stem cells from most biological materials, including cord tissue, placenta, and dental pulp stem cells, leaving only umbilical cord blood banking as permitted and licensed within the country.
While market factors can vary by geography, it is crucial to have a global understanding of the market. Research advances, clinical trial findings, and technology advances do not know international boundaries.
The cord blood market is global in nature and understanding dynamics limited to your region is not sufficient for making strategic, informed, and profitable decisions.
*Cord Blood Report Highlights*
This 265 page report includes:
· Market size determinations for cord blood and tissue storage, with projections to 2022
· Volumes of cord blood and cord tissue storage worldwide
· Rates of worldwide cord blood storage (units per year)
· Rates of cord blood utilization
· Trend rate data for umbilical cord blood grants, patents, and scientific publications
· Clinical trial analysis, including comparison of cord blood vs. cord tissue trials
· Current and future conditions treatable with cord blood
· Regulatory pathways affecting cord blood banking in major healthcare markets
· Digital marketing assessment and comparison of industry leaders
· Competitive environment analysis, including identification of market leaders
· Leading investors within the cord blood marketplace
· Medical opinions of cord blood banking
· Crucial trends and unmet market needs
· And more
*Companies Mentioned *· ABS Capital Partners & HLM Management
· AllCells
· AlphaCord
· AMAG Pharmaceuticals
· Americord
· Bay City Capital
· Biocell Center
· BioEden
· Biosafe
· CariCord
· CBR
· CBR and California Cryobank (CCB)
· Cell Care (Australia)
· Cesca Therapeutics
· China Cord Blood Corporation (CCBC)
· CorCell
· Cord Blood Registry (CBR)
· Cordlife
· Core23 BioBank
· Crioestaminal
· Cryo-Cell International
· Cryoholdco
· Cryolife
· CryoSave
· Dentcell
· Excalibur
· FamiCord Group
· FamilyCord
· Fate Therapeutics
· Future Health Biobank
· Gamida Cell Ltd.
· GeneCell International
· Genesis Bank
· GI Partners
· GTCR, LLC
· HealthBaby
· HealthBanks Biotech Company Ltd
· Human Longevity Inc.
· Insception Lifebank
· KKR & Company
· LifebankUSA
· LifeCell International
· Lonza
· MAZE
· MiracleCord
· Nanjing Cenbest
· Natera, Inc. (EverCordTM)
· National Cord Blood Program (NCBP)
· New England Cord Blood Bank
· Nohla Therapeutics
· Novartis
· PacifiCord
· PerkinElmer
· Pluristem Therapeutics
· Precious Cells Group (now in administration, along with Pharmacells Ltd.)
· PromoCells
· ReeLabs
· Sanpower Group
· Shandong Cord Blood Bank
· Stem Cell Cryobank
· STEMCELL Technologies
· StemCyte
· Stemlab
· Thermo Fisher Scientific
· Transcell Biologics Pvt Ltd,
· VAULT SC Inc.
· ViaCord
· Vita34For more information about this report visit https://www.researchandmarkets.com/research/hxdwp3/global_cord_blood?w=12
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells , Blood Banking Reported by GlobeNewswire 2 hours ago.
↧
Global Xanthan Gum Market 2015-2024: Largely Driven by Food & Beverage and Oil & Gas Sectors, Global Demand for Xanthan Gum is Forecast to Reach 323K Metric Tons
Dublin, Oct. 18, 2018 (GLOBE NEWSWIRE) -- The "Xanthan Gum - A Global Market Overview" report has been added to *ResearchAndMarkets.com's* offering.The report reviews, analyzes and projects the global Xanthan Gum market for the period 2015-2024 in terms of volume in Metric Tons and value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2024.
Food & beverages and oil & gas sectors are the two largest consumers of Xanthan gum globally, where these two applications segments are estimated to corner a market share in excess of 80% together. Xanthan gum is used in wide range food products, such as sauces, dressings, meat and poultry products, bakery products, confectionery products, beverages, dairy products, others. Commercially, Xanthan gum is available in several grades for food & beverages, pharmaceutical, personal care, agricultural, household, oil& gas and other industrial applications.
Global market for Xanthan gum, estimated at 240 thousand metric tons in 2018, is further projected witness a CAGR of 5.1% through to the period 2024. Food & beverages is the largest application segment for Xanthan gum with an estimated share of 46% while the segment also witnesses the fastest growth during the aforementioned analysis period.
*Research Findings & Coverage*
· Xanthan gum global market is analyzed in this report with respect to major end-use applications
· The study exclusively analyzes the market for Xanthan gum applications in all major regions/countries for the analysis period
· Xanthan gum's potential in the oil & gas sector on an upswing
· Xanthan gum becomes the food & beverages industry's favorite
· The global production of Xanthan gum is highly concentrated and top three players account for nearly 70% of the production
· Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
· Major companies profiled - 26
· The industry guide includes the contact details for 122 companies
*Product Outline*
*The following application areas of Xanthan Gum are analyzed in this report:*
· Food & Beverages
· Oil & Gas
· Pharmaceuticals
· Personal Care & Cosmetics
· Other Applications (include household, agriculture and industrial)
*Key Topics Covered:**PART A: GLOBAL MARKET PERSPECTIVE*
*1. INTRODUCTION*
1.1 Product Outline
1.1.1 Definition
1.1.1.1 Structure
1.1.2 Production of Xanthan Gum
1.1.3 Factors Affecting the Xanthan Production
1.1.3.1 Effect of Carbon Sources
1.1.3.2 Effect of Nitrogen Sources
1.1.3.3 Effect of Temperature
1.1.3.4 Effect of pH
1.1.3.5 Effect of Mass Transfer Rate
1.1.4 Functions of Xanthan Gum
1.1.5 Properties of Xanthan Gum
1.1.6 Compatibility and Stability
1.1.7 Advantages of Xanthan Gum over Other Hydrophilic Colloids
1.1.8 Applications of Xanthan Gum
1.1.8.1 Oil & Gas
1.1.8.2 Food and Beverages
1.1.8.3 Personal Care and Cosmetics
1.1.8.4 Pharmaceuticals
1.1.8.5 Other Applications
1.1.9 Xanthan Gum Substitutes
1.1.9.1 Agar Agar
1.1.9.2 Chia Seeds
1.1.9.3 Guar Gum
1.1.9.4 Flax Seeds
1.1.9.5 Gelatin
1.1.9.6 Locust Bean Gum
1.1.9.7 Psyllium Fibre
*2. KEY MARKET TRENDS*
2.1 Xanthan Gum's Potential in the Oil & Gas Sector on an Upswing
2.2 Xanthan Gum Becomes the Food & Beverages Industry's Favorite
2.3 China Facing Anti-Dumping Duties
*3. INDUSTRY LANDSCAPE*
3.1 Key Global Players
· Archer-Daniels-Midland Company (United States)
· Cargill, Incorporated (United States)
· CP Kelco U.S., Inc. (United States)
· DSM Rainbow (Inner Mongolia) Biotechnology Co., Ltd. (China)
· DuPont Nutrition & Health (Denmark)
· Fufeng Group Limited (China)
· Hebei Xinhe Biochemical Co., Ltd (China)
· Jianlong Biotechnology Co., Ltd. (China)
· Jungbunzlauer Suisse AG (Switzerland)
· Meihua Holdings Group Co., Ltd (China)
· Solvay SA (Belgium)
· Zibo Zhongxuan Biochemical Co., Ltd. (Deosen Biochemical Co., Ltd.) (China)
· 3.2 Key Business and Product Trends
· ADM Opens New Technical Innovation Centre, Regional Office in Shanghai
· Majority of Jungbunzlauer Products Obtains Non-GMO Project Verification
· CP Kelco's Xanthan Gum Products Receives Non-GMO Project Verification
· CP Kelco to Enter Indonesian Distribution Partnership with Azelis
· DSM and Haixing Acquires Inner Mongolia Rainbow Biotechnology
· DowDuPont Completes FMC Corporation's Health & Nutrition Business Acquisition
· Ingredion Acquires TIC Gums
· Vegan Xanthan Gum Grades Introduced by Jungbunzlauer
· CP Kelco Inks Distribution Partnership with L.V. Lomas in the United States
· CP Kelco Expands Specialty Biogums Production Capacity
*4. GLOBAL MARKET OVERVIEW*
4.1 Global Xanthan Gum Market Overview by Application
4.1.1 Xanthan Gum Application Market Overview by Global Region
4.1.1.1 Food & Beverages
4.1.1.2 Oil & Gas
4.1.1.3 Pharmaceuticals
4.1.1.4 Personal Care & Cosmetics
4.1.1.5 Other Applications
*PART B: REGIONAL MARKET PERSPECTIVE*
*REGIONAL MARKET OVERVIEW*
*5. NORTH AMERICA*
5.1 North American Xanthan Gum Market Overview by Geographic Region
5.2 North American Xanthan Gum Market Overview by Application
5.3 Major Market Players
· Archer-Daniels-Midland Company (United States)
· Cargill, Incorporated (United States)
· CP Kelco U.S., Inc. (United States)
· Exandal Corp. (United States)
· Ingredion Incorporated (United States)
· Vanderbilt Minerals, LLC (United States)
· Wego Chemical Group (United States)*6. EUROPE*
6.1 European Xanthan Gum Market Overview by Geographic Region
6.2 European Xanthan Gum Market Overview by Application
6.3 Major Market Players
· Cargill France SAS (France)
· DuPont Nutrition & Health (Denmark)
· Jungbunzlauer Suisse AG (Switzerland)
· Solvay SA (Belgium)*7. ASIA-PACIFIC*
7.1 Asia-Pacific Xanthan Gum Market Overview by Geographic Region
7.2 Asia-Pacific Xanthan Gum Market Overview by Application
7.3 Major Market Players
· CP Kelco (Shandong) Biological Co., Ltd. (China)
· Daiichi-Kasei Co., Ltd. (Japan)
· DSM Rainbow (Inner Mongolia) Biotechnology Co., Ltd. (China)
· Fufeng Group Limited (China)
· Hebei Xinhe Biochemical Co., Ltd (China)
· Jianlong Biotechnology Co., Ltd. (China)
· Kantilal Brothers (India)
· Lucid Colloids Ltd. (India)
· Meihua Holdings Group Co., Ltd (China)
· Qingdao Great Chemical Inc. (China)
· Qingdao Unichem International Trade Co., Ltd. (China)
· Qingdao Zoranoc Oilfield Chemical Co., Ltd. (China)
· Vasundhara Industries (India)
· Zibo Zhongxuan Biochemical Co., Ltd. (Deosen Biochemical Co., Ltd) (China)*8. SOUTH AMERICA*
*9. REST OF WORLD*
*PART C: GUIDE TO THE INDUSTRY*
*PART D: ANNEXURE*For more information about this report visit https://www.researchandmarkets.com/research/4j73kc/global_xanthan?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Surfactants, Food Additive Chemicals , Oilfield Chemicals Reported by GlobeNewswire 2 hours ago.
Food & beverages and oil & gas sectors are the two largest consumers of Xanthan gum globally, where these two applications segments are estimated to corner a market share in excess of 80% together. Xanthan gum is used in wide range food products, such as sauces, dressings, meat and poultry products, bakery products, confectionery products, beverages, dairy products, others. Commercially, Xanthan gum is available in several grades for food & beverages, pharmaceutical, personal care, agricultural, household, oil& gas and other industrial applications.
Global market for Xanthan gum, estimated at 240 thousand metric tons in 2018, is further projected witness a CAGR of 5.1% through to the period 2024. Food & beverages is the largest application segment for Xanthan gum with an estimated share of 46% while the segment also witnesses the fastest growth during the aforementioned analysis period.
*Research Findings & Coverage*
· Xanthan gum global market is analyzed in this report with respect to major end-use applications
· The study exclusively analyzes the market for Xanthan gum applications in all major regions/countries for the analysis period
· Xanthan gum's potential in the oil & gas sector on an upswing
· Xanthan gum becomes the food & beverages industry's favorite
· The global production of Xanthan gum is highly concentrated and top three players account for nearly 70% of the production
· Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
· Major companies profiled - 26
· The industry guide includes the contact details for 122 companies
*Product Outline*
*The following application areas of Xanthan Gum are analyzed in this report:*
· Food & Beverages
· Oil & Gas
· Pharmaceuticals
· Personal Care & Cosmetics
· Other Applications (include household, agriculture and industrial)
*Key Topics Covered:**PART A: GLOBAL MARKET PERSPECTIVE*
*1. INTRODUCTION*
1.1 Product Outline
1.1.1 Definition
1.1.1.1 Structure
1.1.2 Production of Xanthan Gum
1.1.3 Factors Affecting the Xanthan Production
1.1.3.1 Effect of Carbon Sources
1.1.3.2 Effect of Nitrogen Sources
1.1.3.3 Effect of Temperature
1.1.3.4 Effect of pH
1.1.3.5 Effect of Mass Transfer Rate
1.1.4 Functions of Xanthan Gum
1.1.5 Properties of Xanthan Gum
1.1.6 Compatibility and Stability
1.1.7 Advantages of Xanthan Gum over Other Hydrophilic Colloids
1.1.8 Applications of Xanthan Gum
1.1.8.1 Oil & Gas
1.1.8.2 Food and Beverages
1.1.8.3 Personal Care and Cosmetics
1.1.8.4 Pharmaceuticals
1.1.8.5 Other Applications
1.1.9 Xanthan Gum Substitutes
1.1.9.1 Agar Agar
1.1.9.2 Chia Seeds
1.1.9.3 Guar Gum
1.1.9.4 Flax Seeds
1.1.9.5 Gelatin
1.1.9.6 Locust Bean Gum
1.1.9.7 Psyllium Fibre
*2. KEY MARKET TRENDS*
2.1 Xanthan Gum's Potential in the Oil & Gas Sector on an Upswing
2.2 Xanthan Gum Becomes the Food & Beverages Industry's Favorite
2.3 China Facing Anti-Dumping Duties
*3. INDUSTRY LANDSCAPE*
3.1 Key Global Players
· Archer-Daniels-Midland Company (United States)
· Cargill, Incorporated (United States)
· CP Kelco U.S., Inc. (United States)
· DSM Rainbow (Inner Mongolia) Biotechnology Co., Ltd. (China)
· DuPont Nutrition & Health (Denmark)
· Fufeng Group Limited (China)
· Hebei Xinhe Biochemical Co., Ltd (China)
· Jianlong Biotechnology Co., Ltd. (China)
· Jungbunzlauer Suisse AG (Switzerland)
· Meihua Holdings Group Co., Ltd (China)
· Solvay SA (Belgium)
· Zibo Zhongxuan Biochemical Co., Ltd. (Deosen Biochemical Co., Ltd.) (China)
· 3.2 Key Business and Product Trends
· ADM Opens New Technical Innovation Centre, Regional Office in Shanghai
· Majority of Jungbunzlauer Products Obtains Non-GMO Project Verification
· CP Kelco's Xanthan Gum Products Receives Non-GMO Project Verification
· CP Kelco to Enter Indonesian Distribution Partnership with Azelis
· DSM and Haixing Acquires Inner Mongolia Rainbow Biotechnology
· DowDuPont Completes FMC Corporation's Health & Nutrition Business Acquisition
· Ingredion Acquires TIC Gums
· Vegan Xanthan Gum Grades Introduced by Jungbunzlauer
· CP Kelco Inks Distribution Partnership with L.V. Lomas in the United States
· CP Kelco Expands Specialty Biogums Production Capacity
*4. GLOBAL MARKET OVERVIEW*
4.1 Global Xanthan Gum Market Overview by Application
4.1.1 Xanthan Gum Application Market Overview by Global Region
4.1.1.1 Food & Beverages
4.1.1.2 Oil & Gas
4.1.1.3 Pharmaceuticals
4.1.1.4 Personal Care & Cosmetics
4.1.1.5 Other Applications
*PART B: REGIONAL MARKET PERSPECTIVE*
*REGIONAL MARKET OVERVIEW*
*5. NORTH AMERICA*
5.1 North American Xanthan Gum Market Overview by Geographic Region
5.2 North American Xanthan Gum Market Overview by Application
5.3 Major Market Players
· Archer-Daniels-Midland Company (United States)
· Cargill, Incorporated (United States)
· CP Kelco U.S., Inc. (United States)
· Exandal Corp. (United States)
· Ingredion Incorporated (United States)
· Vanderbilt Minerals, LLC (United States)
· Wego Chemical Group (United States)*6. EUROPE*
6.1 European Xanthan Gum Market Overview by Geographic Region
6.2 European Xanthan Gum Market Overview by Application
6.3 Major Market Players
· Cargill France SAS (France)
· DuPont Nutrition & Health (Denmark)
· Jungbunzlauer Suisse AG (Switzerland)
· Solvay SA (Belgium)*7. ASIA-PACIFIC*
7.1 Asia-Pacific Xanthan Gum Market Overview by Geographic Region
7.2 Asia-Pacific Xanthan Gum Market Overview by Application
7.3 Major Market Players
· CP Kelco (Shandong) Biological Co., Ltd. (China)
· Daiichi-Kasei Co., Ltd. (Japan)
· DSM Rainbow (Inner Mongolia) Biotechnology Co., Ltd. (China)
· Fufeng Group Limited (China)
· Hebei Xinhe Biochemical Co., Ltd (China)
· Jianlong Biotechnology Co., Ltd. (China)
· Kantilal Brothers (India)
· Lucid Colloids Ltd. (India)
· Meihua Holdings Group Co., Ltd (China)
· Qingdao Great Chemical Inc. (China)
· Qingdao Unichem International Trade Co., Ltd. (China)
· Qingdao Zoranoc Oilfield Chemical Co., Ltd. (China)
· Vasundhara Industries (India)
· Zibo Zhongxuan Biochemical Co., Ltd. (Deosen Biochemical Co., Ltd) (China)*8. SOUTH AMERICA*
*9. REST OF WORLD*
*PART C: GUIDE TO THE INDUSTRY*
*PART D: ANNEXURE*For more information about this report visit https://www.researchandmarkets.com/research/4j73kc/global_xanthan?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Surfactants, Food Additive Chemicals , Oilfield Chemicals Reported by GlobeNewswire 2 hours ago.
↧
Keystone Partners’ Podcast, The Hennessy Report, Celebrates One Year Anniversary
Outplacement and Leadership Coaching Firm Delivers Conversations with Leading HR Executives
BOSTON (PRWEB) October 18, 2018
The Hennessy Report, a free podcast created by Keystone Partners, a leading career management and leadership development consulting firm, in conjunction with the Northeast Human Resources Association (NEHRA), celebrated one year of in-depth, dynamic conversations with the nation’s leading HR executives.
The Hennessy Report discusses critical issues impacting business success and emerging trends impacting the HR sector. Key topics addressed during the 2017/2018 series include leadership transparency, workplace diversity, and talent acquisition.
“HubSpot has always been on a mission to help organizations grow better, and people are a big part of that equation. The Hennessy Report gave me the opportunity to talk about how technology and innovation are disrupting how traditional HR is done, and to learn from other guests on how we can grow and better ourselves,” said Katie Burke, Chief People Officer at HubSpot, who appears on episode 15.
“We spend much of our time trying to come up with some sort of ethical decision-making framework to define gray areas in behavior but we don't spend nearly enough time on preparing folks to act effectively on the ethical concerns that they already perceive,” stated Mary Gentile, Founder of Giving Voice to Values, who appears on episode 17. “Discussing these issues on the podcast spurs broader conversations and collaboration around many of the new challenges that HR professionals face.”
“We launched a forum for the HR community and couldn’t be happier about our influence a year later,” added Dave Hennessy, Senior Vice President of Keystone Partners and Host of The Hennessey Report. “For decades, Keystone Partners has consulted with the top leaders in HR. Now, we have been able to provide listeners access to these top executives and gain perspective from different industries.”
Tracy Burns, CEO of NEHRA added, “The Hennessy Report has established itself as a tremendous resource for HR professionals, providing candid conversations about real issues impacting companies and the profession.”
Since the launch, the Hennessy report has conducted 22 interviews with executives that include Beth Grous, Chief People Officer at TripAdvisor, Ginger Gregory, EVP and Chief Human Resources Officer at Biogen and Paul Lesser, Head of Talent Acquisition at Fidelity Investments. Listeners can find archived copies of the podcast at Keystone Partners’ website (http://www.keystonepartners.com) and through SoundCloud, iTunes, and Google Play.
About Keystone Partners
Keystone Partners is a leading career management and leadership development consulting firm headquartered in Boston, Massachusetts. Keystone works with organizations in New England, the Research Triangle, and around the world to efficiently and effectively address their career management and development needs.
Keystone Partners' divisions include Keystone Associates, which provides comprehensive career management services through executive level; Essex Partners, a premier career consultancy exclusively for senior executives; and Camden Consulting Group, leadership and talent management experts who help leaders and their organizations learn, develop, grow and thrive. Keystone Partners is also a founding partner of Career Partners International. For more information, please visit http://www.keystonepartners.com.
About Career Partners International
Founded in 1987, Career Partners International is a leading provider of Outplacement, Career Management, Executive Coaching and Leadership Development services from more than 350 offices in over 50 countries. Employers around the world trust Career Partners International’s local market experts to provide the best possible outcomes for employees across Canada, the United States, Latin America, Europe, Middle East and Africa, and Asia Pacific regions. Keystone Partners represents Career Partners International in New England and the Research Triangle.
About Northeast Human Resources Association
Founded 30 years ago and with more than 2,000 members, NEHRA is the largest, most influential professional HR organization in the Northeast. NEHRA's goal is to help HR professionals Connect, Grow and Thrive by providing relevant and timely educational programs, access to tools and resources, and offering a variety of opportunities to network with peers. Reported by PRWeb 1 hour ago.
BOSTON (PRWEB) October 18, 2018
The Hennessy Report, a free podcast created by Keystone Partners, a leading career management and leadership development consulting firm, in conjunction with the Northeast Human Resources Association (NEHRA), celebrated one year of in-depth, dynamic conversations with the nation’s leading HR executives.
The Hennessy Report discusses critical issues impacting business success and emerging trends impacting the HR sector. Key topics addressed during the 2017/2018 series include leadership transparency, workplace diversity, and talent acquisition.
“HubSpot has always been on a mission to help organizations grow better, and people are a big part of that equation. The Hennessy Report gave me the opportunity to talk about how technology and innovation are disrupting how traditional HR is done, and to learn from other guests on how we can grow and better ourselves,” said Katie Burke, Chief People Officer at HubSpot, who appears on episode 15.
“We spend much of our time trying to come up with some sort of ethical decision-making framework to define gray areas in behavior but we don't spend nearly enough time on preparing folks to act effectively on the ethical concerns that they already perceive,” stated Mary Gentile, Founder of Giving Voice to Values, who appears on episode 17. “Discussing these issues on the podcast spurs broader conversations and collaboration around many of the new challenges that HR professionals face.”
“We launched a forum for the HR community and couldn’t be happier about our influence a year later,” added Dave Hennessy, Senior Vice President of Keystone Partners and Host of The Hennessey Report. “For decades, Keystone Partners has consulted with the top leaders in HR. Now, we have been able to provide listeners access to these top executives and gain perspective from different industries.”
Tracy Burns, CEO of NEHRA added, “The Hennessy Report has established itself as a tremendous resource for HR professionals, providing candid conversations about real issues impacting companies and the profession.”
Since the launch, the Hennessy report has conducted 22 interviews with executives that include Beth Grous, Chief People Officer at TripAdvisor, Ginger Gregory, EVP and Chief Human Resources Officer at Biogen and Paul Lesser, Head of Talent Acquisition at Fidelity Investments. Listeners can find archived copies of the podcast at Keystone Partners’ website (http://www.keystonepartners.com) and through SoundCloud, iTunes, and Google Play.
About Keystone Partners
Keystone Partners is a leading career management and leadership development consulting firm headquartered in Boston, Massachusetts. Keystone works with organizations in New England, the Research Triangle, and around the world to efficiently and effectively address their career management and development needs.
Keystone Partners' divisions include Keystone Associates, which provides comprehensive career management services through executive level; Essex Partners, a premier career consultancy exclusively for senior executives; and Camden Consulting Group, leadership and talent management experts who help leaders and their organizations learn, develop, grow and thrive. Keystone Partners is also a founding partner of Career Partners International. For more information, please visit http://www.keystonepartners.com.
About Career Partners International
Founded in 1987, Career Partners International is a leading provider of Outplacement, Career Management, Executive Coaching and Leadership Development services from more than 350 offices in over 50 countries. Employers around the world trust Career Partners International’s local market experts to provide the best possible outcomes for employees across Canada, the United States, Latin America, Europe, Middle East and Africa, and Asia Pacific regions. Keystone Partners represents Career Partners International in New England and the Research Triangle.
About Northeast Human Resources Association
Founded 30 years ago and with more than 2,000 members, NEHRA is the largest, most influential professional HR organization in the Northeast. NEHRA's goal is to help HR professionals Connect, Grow and Thrive by providing relevant and timely educational programs, access to tools and resources, and offering a variety of opportunities to network with peers. Reported by PRWeb 1 hour ago.
↧
↧
European Hospital Beds Market Forecast To 2024: Market Expected to reach $1,102.0 Million
Dublin, Oct. 18, 2018 (GLOBE NEWSWIRE) -- The "European Hospital Beds Market By Product (Beds, Accessories), Area Of Use (Critical, Bariatric, Med Surg, Pediatric, Maternal), Technology (Powered, Manual), Type Of Care (Curative, Long Term), And End User (Hospital, Homecare)-Forecast To 2024" report has been added to *ResearchAndMarkets.com's* offering.The factors such as increasing elderly population coupled with the growing prevalence of chronic diseases and the launch of technologically advanced beds are driving the growth of European medical/hospital beds market. Moreover, the emergence of smart beds and robotic beds and growing demand for beds for long-care further supports the growth of this market. However, rising preference for minimally invasive surgeries (eliminating the necessity of longer hospital stays) and the decreasing number of hospitals and hospital beds in some of the European countries hinder the growth of this market.
Medical beds commanded the largest share of European medical/hospital beds market by product in 2017. However, accessories are expected to witness a rapid growth during the forecast period mainly due to the growing demand for custom accessories such as extensions, side rails, and side trays.
The medical beds market for hospitals (end user segment) commanded the largest share of the European market in 2017. This is attributed to growing healthcare expenditure across the region and the increasing prevalence of various acute and chronic diseases resulting in greater admission rates in hospitals.
An in-depth analysis of the European region provides detailed qualitative and quantitative insights of seven regions, namely, Russia, Germany, France, U.K., Italy, Spain, and rest of Europe (RoE). Russia commanded the largest share of the European medical/hospital beds market in 2017, followed by France, the U.K., Germany, Italy, and Spain. The large share of this region is mainly attributed to the factors such as large population base, an ageing population, the prevalence of chronic illnesses, and presence of a large number of hospitals coupled with greater access to healthcare.*Key Topics Covered:**1. Introduction*
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
*2. Research Methodology*
2.1. Secondary Research
2.2. Primary Research
*3. Executive Summary*
*4. Market Insights*
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Elderly Population Coupled with Growing Prevalence of Chronic Diseases
4.2.1.2. Launch of Technologically Advanced Beds
4.2.2. Restraints
4.2.2.1. Growing Preference for Minimally Invasive Surgeries
4.2.2.2. Declining Number of Beds
4.2.3. Opportunities
4.2.3.1. Smart Beds and Robotic Beds to offer New Growth Avenues
4.2.3.2. Growing Demand for Beds for Long-Term Care
4.2.4. Trends
4.2.4.1. Transition from Acute Care to Long-Term Care
4.3. Market Share Analysis
*5. European Hospital/Medical Beds Market, by Product*
5.1. Introduction
5.2. Hospital/Medical Beds
5.3. Accessories
*6. European Hospital/Medical Beds Market, by Area of Use*
6.1. Introduction
6.2. Critical Care
6.3. Long-Term Care
6.4. Bariatric Care
6.5. Med-Surg
6.6. Pediatric Care
6.7. Maternal Care
6.8. Home Care
*7. European Hospital/Medical Beds Market, by Type of Care*
7.1. Introduction
7.2. Curative Care
7.3. Long-Term Care
7.4. Rehabilitative Care
*8. European Hospital/Medical Beds Market, by Technology*
8.1. Introduction
8.2. Powered Beds
8.2.1. Electric Beds
8.2.2. Semi-Electric Beds
8.3. Manual Beds
*9. European Hospital/Medical Beds Market, by End User*
9.1. Introduction
9.2. Hospitals
9.3. Elderly Care Settings
9.4. Home Care Settings
9.5. Others
*10. European Hospital/Medical Beds Market, by Region*
10.1. Introduction
10.1.1. Russia
10.1.2. France
10.1.3. U.K.
10.1.4. Germany
10.1.5. Italy
10.1.6. Spain
10.1.7. Rest of Europe (RoE)
*11. Competitive Landscape*
11.1. New Product Launches
11.2. Agreements
11.3. Acquisitions
*12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)*
12.1. Stryker Corporation
12.2. Hill-Rom Holdings, Inc.
12.3. Getinge AB
12.4. Invacare Corporation
12.5. Paramount Bed Holdings Co., Ltd.
12.6. Medline Industries, Inc.
12.7. Joh. Stiegelmeyer GmbH & Co. KG
12.8. Gendron Inc.
12.9. LINET Group SE
12.10. Joerns Healthcare LLC.
12.11. Span-America Medical Systems, Inc. (A Subsidiary of Savaria Corporation)
12.12. Savion Industries
12.13. Malvestio Spa (A Subsidiary of Malvestio Group)For more information about this report visit https://www.researchandmarkets.com/research/zxdh5q/european_hospital?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hospital Management, Medical Devices Reported by GlobeNewswire 1 hour ago.
Medical beds commanded the largest share of European medical/hospital beds market by product in 2017. However, accessories are expected to witness a rapid growth during the forecast period mainly due to the growing demand for custom accessories such as extensions, side rails, and side trays.
The medical beds market for hospitals (end user segment) commanded the largest share of the European market in 2017. This is attributed to growing healthcare expenditure across the region and the increasing prevalence of various acute and chronic diseases resulting in greater admission rates in hospitals.
An in-depth analysis of the European region provides detailed qualitative and quantitative insights of seven regions, namely, Russia, Germany, France, U.K., Italy, Spain, and rest of Europe (RoE). Russia commanded the largest share of the European medical/hospital beds market in 2017, followed by France, the U.K., Germany, Italy, and Spain. The large share of this region is mainly attributed to the factors such as large population base, an ageing population, the prevalence of chronic illnesses, and presence of a large number of hospitals coupled with greater access to healthcare.*Key Topics Covered:**1. Introduction*
1.1. Market Ecosystem
1.2. Currency and Limitations
1.3. Key Stakeholders
*2. Research Methodology*
2.1. Secondary Research
2.2. Primary Research
*3. Executive Summary*
*4. Market Insights*
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Elderly Population Coupled with Growing Prevalence of Chronic Diseases
4.2.1.2. Launch of Technologically Advanced Beds
4.2.2. Restraints
4.2.2.1. Growing Preference for Minimally Invasive Surgeries
4.2.2.2. Declining Number of Beds
4.2.3. Opportunities
4.2.3.1. Smart Beds and Robotic Beds to offer New Growth Avenues
4.2.3.2. Growing Demand for Beds for Long-Term Care
4.2.4. Trends
4.2.4.1. Transition from Acute Care to Long-Term Care
4.3. Market Share Analysis
*5. European Hospital/Medical Beds Market, by Product*
5.1. Introduction
5.2. Hospital/Medical Beds
5.3. Accessories
*6. European Hospital/Medical Beds Market, by Area of Use*
6.1. Introduction
6.2. Critical Care
6.3. Long-Term Care
6.4. Bariatric Care
6.5. Med-Surg
6.6. Pediatric Care
6.7. Maternal Care
6.8. Home Care
*7. European Hospital/Medical Beds Market, by Type of Care*
7.1. Introduction
7.2. Curative Care
7.3. Long-Term Care
7.4. Rehabilitative Care
*8. European Hospital/Medical Beds Market, by Technology*
8.1. Introduction
8.2. Powered Beds
8.2.1. Electric Beds
8.2.2. Semi-Electric Beds
8.3. Manual Beds
*9. European Hospital/Medical Beds Market, by End User*
9.1. Introduction
9.2. Hospitals
9.3. Elderly Care Settings
9.4. Home Care Settings
9.5. Others
*10. European Hospital/Medical Beds Market, by Region*
10.1. Introduction
10.1.1. Russia
10.1.2. France
10.1.3. U.K.
10.1.4. Germany
10.1.5. Italy
10.1.6. Spain
10.1.7. Rest of Europe (RoE)
*11. Competitive Landscape*
11.1. New Product Launches
11.2. Agreements
11.3. Acquisitions
*12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)*
12.1. Stryker Corporation
12.2. Hill-Rom Holdings, Inc.
12.3. Getinge AB
12.4. Invacare Corporation
12.5. Paramount Bed Holdings Co., Ltd.
12.6. Medline Industries, Inc.
12.7. Joh. Stiegelmeyer GmbH & Co. KG
12.8. Gendron Inc.
12.9. LINET Group SE
12.10. Joerns Healthcare LLC.
12.11. Span-America Medical Systems, Inc. (A Subsidiary of Savaria Corporation)
12.12. Savion Industries
12.13. Malvestio Spa (A Subsidiary of Malvestio Group)For more information about this report visit https://www.researchandmarkets.com/research/zxdh5q/european_hospital?w=12
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hospital Management, Medical Devices Reported by GlobeNewswire 1 hour ago.
↧
FTI Consulting Expands Forensic Technology and Data & Analytics Capabilities in the Middle East, United Kingdom and India
*Industry Experts Bolster Regulatory Compliance, Data & Analytics and Cross-Border Investigations Offerings*LONDON, Oct. 18, 2018 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of five Senior Managing Directors in the Middle East, the United Kingdom and India. The addition of Paul Walker, Amit Jaju, Andrew Pimlott, Muthmainur Rahman and Brian Stuart further enhances the firm’s international forensic technology and data & analytics capabilities to support the increasingly global and data-driven nature of legal and regulatory concerns.
Each of these experts specialise in leading large, complex cross-border matters and supporting clients on a range of issues, including compliance, remediation, regulatory, disputes and financial crime matters. Their depth of experience supports FTI Consulting’s strengths in fraud investigations, economic sanctions, and license and intellectual property compliance.
Commenting on these appointments, Kevin Hewitt, Chairman of the Europe, Middle East and Africa (“EMEA”) region at FTI Consulting, said, “I am delighted to welcome each of these senior leaders into our firm. Collectively, they represent a significant investment in our forensic technology and data analytics capabilities that will enhance our ability to provide clients with the expertise and experience needed to navigate today’s dynamic and rapidly changing legal and regulatory landscape.”
Paul Walker joins as a Senior Managing Director and Head of EMEA Technology and will be based in Dubai. Previously, Mr. Walker was a Partner at EY, leading the Forensic Technology practice across the Europe, Middle East, India and Africa region. In this role, he was responsible for building the firm’s e-discovery, advanced data analytics, license compliance and cybersecurity services offerings. Mr. Walker also delivered sophisticated data-driven fraud detection solutions and led numerous complex cross-border litigation proceedings and regulatory reviews. Prior to that, Mr. Walker led the Technology businesses at Andersen Consulting, BAE Systems and KPMG.
Amit Jaju joins as a Senior Managing Director and Head of India Technology and will be based in Mumbai. Previously, Mr. Jaju was a Partner and Head of Forensic Technology at EY India. In this role, he created market-leading solutions for financial crime, cyber incident response, analytics and software licensing for both domestic and international clients. Mr. Jaju specialises in assisting clients in addressing matters related to cybersecurity compliance, revenue leakage, regulations, fraud, corruption, data theft and insider threats, among other issues requiring innovative technological solutions.
Andrew Pimlott joins as a Senior Managing Director in the Data & Analytics practice within the Forensic & Litigation Consulting segment and will be based in London. Before joining FTI Consulting, Mr. Pimlott was a Partner at Deloitte and led its Forensic Technology practice in the Middle East. Prior to Deloitte, he was a Partner with EY in the Middle East. Mr. Pimlott brings sophisticated analytics and regulatory expertise to large-scale financial services investigations, with deep financial crimes expertise, including anti-money laundering, terrorist financing, economic sanctions and anti-bribery and anti-corruption. He has led his clients, who are among the world’s largest financial institutions, through multifaceted and impactful regulatory enforcement and legal matters, representing them before the U.S. Treasury Office of Foreign Assets Control (“OFAC”), Department of Justice and Federal Bureau of Investigation, as well as EMEA regulators.
Muthmainur Rahman joins as a Senior Managing Director and Middle East Head of Technology and will be based in Dubai. Prior to joining FTI Consulting, Mr. Rahman developed an advanced Forensic Data Analytics team at EY. Mr. Rahman has a strong track record of identifying, pursuing and delivering global engagements across the U.S., Europe, Middle East and India. He specialises in responding to financial investigations, competition market abuse, economic sanctions violations, LIBOR rate manipulation, billion-dollar bankruptcies and global anti-bribery reviews.
Brian Stuart joins as a Senior Managing Director in the Technology segment and will be based in London. Mr. Stuart joins FTI Consulting from EY. He brings 25 years of experience helping clients and law firms deal with disruptive regulatory challenges and litigious matters. Mr. Stuart combines traditional e-discovery review with advanced structured analytics to help clients address issues, including bribery and corruption, Foreign Corrupt Practices Act investigations, OFAC sanctions breaches, competition enquiries, product liability and contract disputes. Much of his work has involved dealing with U.S. regulatory matters, where he led international teams in the life sciences and financial services sectors.
Mr. Walker, Head of EMEA Technology, commented, “I am delighted to be joining FTI Consulting and their Technology business. I look forward to leveraging their considerable platform and global network of experts to deliver a range of technology services that we believe will be very much in demand in the coming years.”
*About FTI Consulting*
FTI Consulting, Inc. is a global business advisory firm dedicated to helping organisations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 4,600 employees located in 28 countries, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated $1.81 billion in revenues during fiscal year 2017. For more information, visit www.fticonsulting.com and connect with us on Twitter (@FTIConsulting), Facebook and LinkedIn.
*FTI Consulting, Inc.*
200 Aldersgate
Aldersgate Street
London EC1A 4HD
*Investor Contact:
*Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com
*Media Contact:
*Michael Rosen
+44.20.3727.1751
michael.rosen@fticonsulting.com Reported by GlobeNewswire 1 hour ago.
Each of these experts specialise in leading large, complex cross-border matters and supporting clients on a range of issues, including compliance, remediation, regulatory, disputes and financial crime matters. Their depth of experience supports FTI Consulting’s strengths in fraud investigations, economic sanctions, and license and intellectual property compliance.
Commenting on these appointments, Kevin Hewitt, Chairman of the Europe, Middle East and Africa (“EMEA”) region at FTI Consulting, said, “I am delighted to welcome each of these senior leaders into our firm. Collectively, they represent a significant investment in our forensic technology and data analytics capabilities that will enhance our ability to provide clients with the expertise and experience needed to navigate today’s dynamic and rapidly changing legal and regulatory landscape.”
Paul Walker joins as a Senior Managing Director and Head of EMEA Technology and will be based in Dubai. Previously, Mr. Walker was a Partner at EY, leading the Forensic Technology practice across the Europe, Middle East, India and Africa region. In this role, he was responsible for building the firm’s e-discovery, advanced data analytics, license compliance and cybersecurity services offerings. Mr. Walker also delivered sophisticated data-driven fraud detection solutions and led numerous complex cross-border litigation proceedings and regulatory reviews. Prior to that, Mr. Walker led the Technology businesses at Andersen Consulting, BAE Systems and KPMG.
Amit Jaju joins as a Senior Managing Director and Head of India Technology and will be based in Mumbai. Previously, Mr. Jaju was a Partner and Head of Forensic Technology at EY India. In this role, he created market-leading solutions for financial crime, cyber incident response, analytics and software licensing for both domestic and international clients. Mr. Jaju specialises in assisting clients in addressing matters related to cybersecurity compliance, revenue leakage, regulations, fraud, corruption, data theft and insider threats, among other issues requiring innovative technological solutions.
Andrew Pimlott joins as a Senior Managing Director in the Data & Analytics practice within the Forensic & Litigation Consulting segment and will be based in London. Before joining FTI Consulting, Mr. Pimlott was a Partner at Deloitte and led its Forensic Technology practice in the Middle East. Prior to Deloitte, he was a Partner with EY in the Middle East. Mr. Pimlott brings sophisticated analytics and regulatory expertise to large-scale financial services investigations, with deep financial crimes expertise, including anti-money laundering, terrorist financing, economic sanctions and anti-bribery and anti-corruption. He has led his clients, who are among the world’s largest financial institutions, through multifaceted and impactful regulatory enforcement and legal matters, representing them before the U.S. Treasury Office of Foreign Assets Control (“OFAC”), Department of Justice and Federal Bureau of Investigation, as well as EMEA regulators.
Muthmainur Rahman joins as a Senior Managing Director and Middle East Head of Technology and will be based in Dubai. Prior to joining FTI Consulting, Mr. Rahman developed an advanced Forensic Data Analytics team at EY. Mr. Rahman has a strong track record of identifying, pursuing and delivering global engagements across the U.S., Europe, Middle East and India. He specialises in responding to financial investigations, competition market abuse, economic sanctions violations, LIBOR rate manipulation, billion-dollar bankruptcies and global anti-bribery reviews.
Brian Stuart joins as a Senior Managing Director in the Technology segment and will be based in London. Mr. Stuart joins FTI Consulting from EY. He brings 25 years of experience helping clients and law firms deal with disruptive regulatory challenges and litigious matters. Mr. Stuart combines traditional e-discovery review with advanced structured analytics to help clients address issues, including bribery and corruption, Foreign Corrupt Practices Act investigations, OFAC sanctions breaches, competition enquiries, product liability and contract disputes. Much of his work has involved dealing with U.S. regulatory matters, where he led international teams in the life sciences and financial services sectors.
Mr. Walker, Head of EMEA Technology, commented, “I am delighted to be joining FTI Consulting and their Technology business. I look forward to leveraging their considerable platform and global network of experts to deliver a range of technology services that we believe will be very much in demand in the coming years.”
*About FTI Consulting*
FTI Consulting, Inc. is a global business advisory firm dedicated to helping organisations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 4,600 employees located in 28 countries, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated $1.81 billion in revenues during fiscal year 2017. For more information, visit www.fticonsulting.com and connect with us on Twitter (@FTIConsulting), Facebook and LinkedIn.
*FTI Consulting, Inc.*
200 Aldersgate
Aldersgate Street
London EC1A 4HD
*Investor Contact:
*Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com
*Media Contact:
*Michael Rosen
+44.20.3727.1751
michael.rosen@fticonsulting.com Reported by GlobeNewswire 1 hour ago.
↧
Armistice events for the young generation.
Thursday 18 October, 2018Two weeks series of events starting with the following:
Thursday 1stand Friday 2ndNovember: first public screenings of
THE GOOD SOLDIER SCHWEJK.
The new film adaptation of “The Good Soldier Schwejk” fits in a long history of antiwar satire started with author Jaroslav Hasek's cabaret stage adaptation in 1920's Prague. Since then Schwejk has represented the common man's opposition to the absurdity of war. In Eastern and Central Europe, Schwejk is a household name. In Britain, he first appeared with Joan Littlewood in a 1939 stage adaptation. In 1943 he featured in comedy films made at Merton Park Studios to protest Fascist ideology. Bertolt Brecht brought him into WWII. In 1954 he reappeared in Stratford East and was the first Joan Littlewood stage production to transfer to the Westend. In the 60's and 70's, Schwejk inspired “Oh What a Lovely War!”. And now, 100 years since the armistice, he is back again: at Sands Films Studio in Rotherhithe. In this new film he is performed by ALFIE STEWART; at 23 yr he is the same age as real lifeSoldier Straslipka, who inspired Hasek's “Soldier Schwejk”. Alfie Stewart is closer to the Iraq War and to the Syrian tragedy than to the horrors of the Somme, but that is the point; Alfie Stewart's Schwejk speaks to the younger generation.
Director Christine Edzard and some members of the cast will be present at the screenings and will engage with the audience.
Saturday 3rdNovember: Two (free) powerful plays by Journeymen Theatre for the young
OVER THE TOP (2.30)
Shows the dilemma created when two contrasting points of view over the role of the military in our schools clash and come to a head-on confrontation.
Kathy Wooton is a Quaker and a passionate advocate for peace whereas the headmaster of her son’s school, Dr Roberts is a pragmatic man who can’t see the problem and feels engaging with the Armed Forces brings nothing but positive advantages into Meadow Springs Academy. As this is forum theatre it is intended to promote discussion and exchange of ideas. The show itself is there to prompt this debate with the school goers and students.
Ellis Brooks, Peace Campaigner and Peace Education Worker at Friends House will also be part of the forum discussion.
About the writers/performers: Lynn and Dave Morris are both highly experienced writers and performers of issue-based theatre. They have worked extensively in schools, colleges and with young offenders. In addition to developing drama projects, Lynn also works as a Peace Education practitioner with the West Midland Quaker Peace Education Project.
Over the Top is performed for free: it is made possible with funding and support received through Central England Quaker Peace Committee.
AND THE BEAT GOES ON (7.30)
Nonviolent Direct Action has been part of the Quaker way for over three hundred years. It has always taken many forms from the power of the pen, through to practical measures verging on the subversive, and the sheer ingenuity of creative nonviolence.
Its purpose has always been clear: to challenge injustice and inequality, even that which is embedded within law; to oppose war; to speak truth to power. To do these things it may be necessary to unsettle and stimulate, or to put it another way, it’s sometimes necessary to make ‘beautiful trouble’.
This performance has been commissioned by John and Diana Lampe. There is no charge for performance but we welcome donations for their work with Seir Women’s Co-operative, West Bank, Palestine.
Sunday 4thNovember: Three outstanding pacifist films set in WWI
NIEMANDSLAND (14.30)
The film takes place in a WWI trench, where five individuals, soldiers and civilians, all from different nations, have been unwillingly thrust together.Despising each other at first, the five protagonists come to realize that they must learn to get along to survive. The pacifistic sentiments (not to mention the ethnic mix) of Niemansland would be verboten by the Nazi regime; indeed, all copies of this film were ordered to be destroyed by propaganda minister Joseph Goebbels. The only surviving copy was the one sent to the US Communist party... This film has never been shown in the UK: this screening is its premiere 87 years after its making, 100 years since they told us it would be the last war.
Introducing the screening, there will be a short tribute to ROSA LUXEMBURG (1871-1919) World famous socialist and pacifist, summarily executed aged 47.
OKRAINA(17.00)
A masterpiece of early Soviet sound film (1932), directed by little known Boris Barnet and a brilliant antiwar film. Set in a small town on the outer regions of imperial Russia, this is WWI as experienced by people who would never engage in such a thing and are being forced into it. The film relates the big historical moments of the Russian Revolution as a distant background to the human realities of life in a small community. Gorgeous, lyrical, comical and uplifting.
JOYEUX NOEL (19.30)
Amnesty International (Tower Hamlets and Newham Group) Film Screening.
Based on true stories, this 2005 French film written and directed by Christian Carion is set in December 1914: an unofficial Christmas truce on the Western Front allows soldiers from opposing sides of the First World War to gain insight into each other's way of life.
The proceeds of this screening will be presented to AMNESTY INTERNATIONAL.
Representatives of Amnesty International will be present and talk at the screening.
*www.sandsfilms.co.uk
* For more information regarding media usage, ownership and rights please contact Sands Films Studio.
Distributed by http://www.pressat.co.uk/* Reported by Pressat 1 hour ago.
Thursday 1stand Friday 2ndNovember: first public screenings of
THE GOOD SOLDIER SCHWEJK.
The new film adaptation of “The Good Soldier Schwejk” fits in a long history of antiwar satire started with author Jaroslav Hasek's cabaret stage adaptation in 1920's Prague. Since then Schwejk has represented the common man's opposition to the absurdity of war. In Eastern and Central Europe, Schwejk is a household name. In Britain, he first appeared with Joan Littlewood in a 1939 stage adaptation. In 1943 he featured in comedy films made at Merton Park Studios to protest Fascist ideology. Bertolt Brecht brought him into WWII. In 1954 he reappeared in Stratford East and was the first Joan Littlewood stage production to transfer to the Westend. In the 60's and 70's, Schwejk inspired “Oh What a Lovely War!”. And now, 100 years since the armistice, he is back again: at Sands Films Studio in Rotherhithe. In this new film he is performed by ALFIE STEWART; at 23 yr he is the same age as real lifeSoldier Straslipka, who inspired Hasek's “Soldier Schwejk”. Alfie Stewart is closer to the Iraq War and to the Syrian tragedy than to the horrors of the Somme, but that is the point; Alfie Stewart's Schwejk speaks to the younger generation.
Director Christine Edzard and some members of the cast will be present at the screenings and will engage with the audience.
Saturday 3rdNovember: Two (free) powerful plays by Journeymen Theatre for the young
OVER THE TOP (2.30)
Shows the dilemma created when two contrasting points of view over the role of the military in our schools clash and come to a head-on confrontation.
Kathy Wooton is a Quaker and a passionate advocate for peace whereas the headmaster of her son’s school, Dr Roberts is a pragmatic man who can’t see the problem and feels engaging with the Armed Forces brings nothing but positive advantages into Meadow Springs Academy. As this is forum theatre it is intended to promote discussion and exchange of ideas. The show itself is there to prompt this debate with the school goers and students.
Ellis Brooks, Peace Campaigner and Peace Education Worker at Friends House will also be part of the forum discussion.
About the writers/performers: Lynn and Dave Morris are both highly experienced writers and performers of issue-based theatre. They have worked extensively in schools, colleges and with young offenders. In addition to developing drama projects, Lynn also works as a Peace Education practitioner with the West Midland Quaker Peace Education Project.
Over the Top is performed for free: it is made possible with funding and support received through Central England Quaker Peace Committee.
AND THE BEAT GOES ON (7.30)
Nonviolent Direct Action has been part of the Quaker way for over three hundred years. It has always taken many forms from the power of the pen, through to practical measures verging on the subversive, and the sheer ingenuity of creative nonviolence.
Its purpose has always been clear: to challenge injustice and inequality, even that which is embedded within law; to oppose war; to speak truth to power. To do these things it may be necessary to unsettle and stimulate, or to put it another way, it’s sometimes necessary to make ‘beautiful trouble’.
This performance has been commissioned by John and Diana Lampe. There is no charge for performance but we welcome donations for their work with Seir Women’s Co-operative, West Bank, Palestine.
Sunday 4thNovember: Three outstanding pacifist films set in WWI
NIEMANDSLAND (14.30)
The film takes place in a WWI trench, where five individuals, soldiers and civilians, all from different nations, have been unwillingly thrust together.Despising each other at first, the five protagonists come to realize that they must learn to get along to survive. The pacifistic sentiments (not to mention the ethnic mix) of Niemansland would be verboten by the Nazi regime; indeed, all copies of this film were ordered to be destroyed by propaganda minister Joseph Goebbels. The only surviving copy was the one sent to the US Communist party... This film has never been shown in the UK: this screening is its premiere 87 years after its making, 100 years since they told us it would be the last war.
Introducing the screening, there will be a short tribute to ROSA LUXEMBURG (1871-1919) World famous socialist and pacifist, summarily executed aged 47.
OKRAINA(17.00)
A masterpiece of early Soviet sound film (1932), directed by little known Boris Barnet and a brilliant antiwar film. Set in a small town on the outer regions of imperial Russia, this is WWI as experienced by people who would never engage in such a thing and are being forced into it. The film relates the big historical moments of the Russian Revolution as a distant background to the human realities of life in a small community. Gorgeous, lyrical, comical and uplifting.
JOYEUX NOEL (19.30)
Amnesty International (Tower Hamlets and Newham Group) Film Screening.
Based on true stories, this 2005 French film written and directed by Christian Carion is set in December 1914: an unofficial Christmas truce on the Western Front allows soldiers from opposing sides of the First World War to gain insight into each other's way of life.
The proceeds of this screening will be presented to AMNESTY INTERNATIONAL.
Representatives of Amnesty International will be present and talk at the screening.
*www.sandsfilms.co.uk
* For more information regarding media usage, ownership and rights please contact Sands Films Studio.
Distributed by http://www.pressat.co.uk/* Reported by Pressat 1 hour ago.
↧
What the hell has happened to Bayern Munich? Time for Kovac to drop under-performing stars
The Bavarians are sixth after back-to-back defeats and are also stuttering in Europe, but what is behind their recent run of poor displays?
Reported by Goal.com 52 minutes ago.
↧
↧
Cyprus airline Cobalt halts flights amid lack of investment
NICOSIA, Cyprus (AP) — Cyprus-based airline Cobalt Air says it has indefinitely suspended all of its operations amid a struggle to find investors. A senior executive from the airline, Philokypros Roussounides, told The Associated Press on Thursday that Cobalt's six Airbus passenger jets have been grounded. Cobalt flies to 22 destinations in Europe and the Middle East. Roussounides said there's still interest by some companies to invest in the airline because of its successful branding, strong reputation and high level of services. Roussounides said passengers were eligible for full refunds. Cobalt Air began flying in 2016 in the wake of the collapse of national carrier Cyprus Airways.
Reported by SeattlePI.com 1 hour ago.
↧
Net Asset Value(s)
*WisdomTree Issuer plc – Daily Fund Prices * *17-October-18*
* * * *
WisdomTree AT1 CoCo Bond UCITS ETF – USD 17/10/2018 IE00BZ0XVF52 328045 USD 31,396,297.07 95.7073
WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 17/10/2018 IE00BFNNN236 20828 EUR 2,069,743.50 99.3731
WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 17/10/2018 IE00BFNNN459 20740 GBP 2,066,150.99 99.6216
WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc 17/10/2018 IE00BZ0XVG69 9000 USD 865,203.07 96.1337
WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged 17/10/2018 IE00BFNNN012 20962 USD 2,092,824.08 99.839
WisdomTree CBOE S&P 500 PutWrite UCITS ETF - USD Acc 17/10/2018 IE00BD49R243 1680000 USD 84,910,516.00 50.542
WisdomTree Emerging Asia Equity Income UCITS ETF 17/10/2018 IE00BYPGT035 1125000 USD 11,960,331.93 10.6314
WisdomTree Emerging Markets Equity Income UCITS ETF 17/10/2018 IE00BQQ3Q067 2042097 USD 30,577,934.25 14.9738
WisdomTree Emerging Markets Equity Income UCITS ETF Acc 17/10/2018 IE00BDF12W49 108242 USD 2,048,534.89 18.9255
WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJBM26 1375000 USD 21,860,698.08 15.8987
WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc 17/10/2018 IE00BG88WG77 25000 EUR 256,084.85 10.2434
WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc 17/10/2018 IE00BG88WH84 1325000 GBP 13,599,559.02 10.2638
WisdomTree Enhanced Commodity UCITS ETF - USD 17/10/2018 IE00BZ1GHD37 525000 USD 5,664,960.32 10.7904
WisdomTree Enhanced Commodity UCITS ETF - USD Acc 17/10/2018 IE00BYMLZY74 12450000 USD 134,933,219.72 10.838
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR 17/10/2018 IE00BD49R912 30000 EUR 1,479,773.21 49.3258
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc 17/10/2018 IE00BD49RB39 30000 EUR 1,479,774.20 49.3258
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF 17/10/2018 IE00BD49RJ15 30000 EUR 1,464,921.29 48.8307
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc 17/10/2018 IE00BD49RK20 30000 EUR 1,464,921.67 48.8307
WisdomTree Europe Equity Income UCITS ETF 17/10/2018 IE00BQZJBX31 3548600 EUR 44,610,040.09 12.5712
WisdomTree Europe Equity Income UCITS ETF Acc 17/10/2018 IE00BDF16007 40010 EUR 574,350.79 14.3552
WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZT11 17096 CHF 269,249.14 15.7492
WisdomTree Europe Equity UCITS ETF - EUR Acc 17/10/2018 IE00BYQCZX56 1304306 EUR 20,852,457.60 15.9874
WisdomTree Europe Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BYQCZQ89 372454 GBP 3,908,684.19 10.4944
WisdomTree Europe Equity UCITS ETF - USD Hedged 17/10/2018 IE00BVXBH163 3215375 USD 53,246,347.99 16.5599
WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 17/10/2018 IE00BYQCZP72 3413137 USD 63,708,952.59 18.6658
WisdomTree Europe Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJC527 3679859 EUR 59,625,432.22 16.2032
WisdomTree Europe Small Cap Dividend UCITS ETF Acc 17/10/2018 IE00BDF16114 771490 EUR 10,845,901.60 14.0584
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR 17/10/2018 IE00BZ56SY76 416881 EUR 5,908,169.97 14.1723
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 17/10/2018 IE00BZ56TQ67 938013 EUR 14,686,759.74 15.6573
WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZ914 45884 CHF 794,181.31 17.3085
WisdomTree Germany Equity UCITS ETF - EUR Acc 17/10/2018 IE00BYQCZC44 251123 EUR 3,868,181.69 15.4035
WisdomTree Germany Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BVXBGY20 507894 GBP 4,901,247.57 9.6501
WisdomTree Germany Equity UCITS ETF - USD Hedged 17/10/2018 IE00BYQCZ682 17536 USD 300,222.14 17.1203
WisdomTree Global Quality Dividend Growth UCITS ETF - USD 17/10/2018 IE00BZ56RN96 88688 USD 1,812,004.40 20.4312
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 17/10/2018 IE00BZ56SW52 430680 USD 9,135,145.37 21.211
WisdomTree India Quality UCITS ETF - USD 17/10/2018 IE00BDGSNK96 152500 USD 2,418,738.00 15.8606
WisdomTree India Quality UCITS ETF - USD Acc 17/10/2018 IE00BDGSNL04 222500 USD 3,536,790.86 15.8957
WisdomTree ISEQ 20 UCITS ETF 17/10/2018 IE00BVFB1H83 1300000 EUR 16,354,441.38 12.5803
WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZL35 202445 CHF 3,843,761.93 18.9867
WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 17/10/2018 IE00BYQCZJ13 664839 EUR 10,853,184.89 16.3245
WisdomTree Japan Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BYQCZF74 146865 GBP 1,606,396.24 10.9379
WisdomTree Japan Equity UCITS ETF - JPY Acc 17/10/2018 IE00BYQCZN58 2333721 USD 45,651,285.29 19.5616
WisdomTree Japan Equity UCITS ETF - USD Hedged 17/10/2018 IE00BVXC4854 8468036 USD 139,444,198.91 16.4671
WisdomTree Japan Equity UCITS ETF - USD Hedged Acc 17/10/2018 IE00BYQCZD50 736932 USD 13,214,811.67 17.9322
WisdomTree Japan SmallCap Dividend UCITS ETF - USD 17/10/2018 IE00BFXYK923 20000 USD 980,646.47 49.0323
WisdomTree Japan SmallCap Dividend UCITS ETF - USD Acc 17/10/2018 IE00BFXYKD63 20000 USD 980,646.51 49.0323
WisdomTree UK Equity Income UCITS ETF 17/10/2018 IE00BYPGTJ26 840000 GBP 4,417,570.99 5.259
WisdomTree US Equity Income UCITS ETF 17/10/2018 IE00BQZJBQ63 1502087 USD 28,808,024.54 19.1787
WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc 17/10/2018 IE00BD6RZW23 24773 EUR 407,124.87 16.4342
WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 17/10/2018 IE00BD6RZZ53 155031 GBP 2,287,376.34 14.7543
WisdomTree US Equity Income UCITS ETF Acc 17/10/2018 IE00BD6RZT93 223095 USD 4,213,761.03 18.8877
WisdomTree US Multifactor UCITS ETF – USD 17/10/2018 IE00BD8ZCY59 10000 USD 500,203.43 50.0203
WisdomTree US Multifactor UCITS ETF – USD Acc 17/10/2018 IE00BD8ZD313 10000 USD 500,203.36 50.0203
WisdomTree US Quality Dividend Growth UCITS ETF - USD 17/10/2018 IE00BZ56RD98 42491 USD 929,106.90 21.866
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 17/10/2018 IE00BZ56RG20 687537 USD 15,530,635.21 22.5888
WisdomTree US Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJBT94 650000 USD 13,027,788.66 20.0428 Reported by GlobeNewswire 55 minutes ago.
* * * *
WisdomTree AT1 CoCo Bond UCITS ETF – USD 17/10/2018 IE00BZ0XVF52 328045 USD 31,396,297.07 95.7073
WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 17/10/2018 IE00BFNNN236 20828 EUR 2,069,743.50 99.3731
WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 17/10/2018 IE00BFNNN459 20740 GBP 2,066,150.99 99.6216
WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc 17/10/2018 IE00BZ0XVG69 9000 USD 865,203.07 96.1337
WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged 17/10/2018 IE00BFNNN012 20962 USD 2,092,824.08 99.839
WisdomTree CBOE S&P 500 PutWrite UCITS ETF - USD Acc 17/10/2018 IE00BD49R243 1680000 USD 84,910,516.00 50.542
WisdomTree Emerging Asia Equity Income UCITS ETF 17/10/2018 IE00BYPGT035 1125000 USD 11,960,331.93 10.6314
WisdomTree Emerging Markets Equity Income UCITS ETF 17/10/2018 IE00BQQ3Q067 2042097 USD 30,577,934.25 14.9738
WisdomTree Emerging Markets Equity Income UCITS ETF Acc 17/10/2018 IE00BDF12W49 108242 USD 2,048,534.89 18.9255
WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJBM26 1375000 USD 21,860,698.08 15.8987
WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc 17/10/2018 IE00BG88WG77 25000 EUR 256,084.85 10.2434
WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc 17/10/2018 IE00BG88WH84 1325000 GBP 13,599,559.02 10.2638
WisdomTree Enhanced Commodity UCITS ETF - USD 17/10/2018 IE00BZ1GHD37 525000 USD 5,664,960.32 10.7904
WisdomTree Enhanced Commodity UCITS ETF - USD Acc 17/10/2018 IE00BYMLZY74 12450000 USD 134,933,219.72 10.838
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR 17/10/2018 IE00BD49R912 30000 EUR 1,479,773.21 49.3258
WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc 17/10/2018 IE00BD49RB39 30000 EUR 1,479,774.20 49.3258
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF 17/10/2018 IE00BD49RJ15 30000 EUR 1,464,921.29 48.8307
WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc 17/10/2018 IE00BD49RK20 30000 EUR 1,464,921.67 48.8307
WisdomTree Europe Equity Income UCITS ETF 17/10/2018 IE00BQZJBX31 3548600 EUR 44,610,040.09 12.5712
WisdomTree Europe Equity Income UCITS ETF Acc 17/10/2018 IE00BDF16007 40010 EUR 574,350.79 14.3552
WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZT11 17096 CHF 269,249.14 15.7492
WisdomTree Europe Equity UCITS ETF - EUR Acc 17/10/2018 IE00BYQCZX56 1304306 EUR 20,852,457.60 15.9874
WisdomTree Europe Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BYQCZQ89 372454 GBP 3,908,684.19 10.4944
WisdomTree Europe Equity UCITS ETF - USD Hedged 17/10/2018 IE00BVXBH163 3215375 USD 53,246,347.99 16.5599
WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 17/10/2018 IE00BYQCZP72 3413137 USD 63,708,952.59 18.6658
WisdomTree Europe Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJC527 3679859 EUR 59,625,432.22 16.2032
WisdomTree Europe Small Cap Dividend UCITS ETF Acc 17/10/2018 IE00BDF16114 771490 EUR 10,845,901.60 14.0584
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR 17/10/2018 IE00BZ56SY76 416881 EUR 5,908,169.97 14.1723
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 17/10/2018 IE00BZ56TQ67 938013 EUR 14,686,759.74 15.6573
WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZ914 45884 CHF 794,181.31 17.3085
WisdomTree Germany Equity UCITS ETF - EUR Acc 17/10/2018 IE00BYQCZC44 251123 EUR 3,868,181.69 15.4035
WisdomTree Germany Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BVXBGY20 507894 GBP 4,901,247.57 9.6501
WisdomTree Germany Equity UCITS ETF - USD Hedged 17/10/2018 IE00BYQCZ682 17536 USD 300,222.14 17.1203
WisdomTree Global Quality Dividend Growth UCITS ETF - USD 17/10/2018 IE00BZ56RN96 88688 USD 1,812,004.40 20.4312
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 17/10/2018 IE00BZ56SW52 430680 USD 9,135,145.37 21.211
WisdomTree India Quality UCITS ETF - USD 17/10/2018 IE00BDGSNK96 152500 USD 2,418,738.00 15.8606
WisdomTree India Quality UCITS ETF - USD Acc 17/10/2018 IE00BDGSNL04 222500 USD 3,536,790.86 15.8957
WisdomTree ISEQ 20 UCITS ETF 17/10/2018 IE00BVFB1H83 1300000 EUR 16,354,441.38 12.5803
WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 17/10/2018 IE00BYQCZL35 202445 CHF 3,843,761.93 18.9867
WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 17/10/2018 IE00BYQCZJ13 664839 EUR 10,853,184.89 16.3245
WisdomTree Japan Equity UCITS ETF - GBP Hedged 17/10/2018 IE00BYQCZF74 146865 GBP 1,606,396.24 10.9379
WisdomTree Japan Equity UCITS ETF - JPY Acc 17/10/2018 IE00BYQCZN58 2333721 USD 45,651,285.29 19.5616
WisdomTree Japan Equity UCITS ETF - USD Hedged 17/10/2018 IE00BVXC4854 8468036 USD 139,444,198.91 16.4671
WisdomTree Japan Equity UCITS ETF - USD Hedged Acc 17/10/2018 IE00BYQCZD50 736932 USD 13,214,811.67 17.9322
WisdomTree Japan SmallCap Dividend UCITS ETF - USD 17/10/2018 IE00BFXYK923 20000 USD 980,646.47 49.0323
WisdomTree Japan SmallCap Dividend UCITS ETF - USD Acc 17/10/2018 IE00BFXYKD63 20000 USD 980,646.51 49.0323
WisdomTree UK Equity Income UCITS ETF 17/10/2018 IE00BYPGTJ26 840000 GBP 4,417,570.99 5.259
WisdomTree US Equity Income UCITS ETF 17/10/2018 IE00BQZJBQ63 1502087 USD 28,808,024.54 19.1787
WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc 17/10/2018 IE00BD6RZW23 24773 EUR 407,124.87 16.4342
WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 17/10/2018 IE00BD6RZZ53 155031 GBP 2,287,376.34 14.7543
WisdomTree US Equity Income UCITS ETF Acc 17/10/2018 IE00BD6RZT93 223095 USD 4,213,761.03 18.8877
WisdomTree US Multifactor UCITS ETF – USD 17/10/2018 IE00BD8ZCY59 10000 USD 500,203.43 50.0203
WisdomTree US Multifactor UCITS ETF – USD Acc 17/10/2018 IE00BD8ZD313 10000 USD 500,203.36 50.0203
WisdomTree US Quality Dividend Growth UCITS ETF - USD 17/10/2018 IE00BZ56RD98 42491 USD 929,106.90 21.866
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 17/10/2018 IE00BZ56RG20 687537 USD 15,530,635.21 22.5888
WisdomTree US Small Cap Dividend UCITS ETF 17/10/2018 IE00BQZJBT94 650000 USD 13,027,788.66 20.0428 Reported by GlobeNewswire 55 minutes ago.
↧
Newcastle to go for Origi or Solanke
According to Newcastle Chronicle, Newcastle United are preparing to dip into the winter transfer market for a striker, an attacking midfielder and a left-back. Manager Rafa Benitez has reportedly asked a number of clubs across Europe to keep him notified of their players’ availability in January, the month that he sees as crucial for their […]
The post Newcastle to go for Origi or Solanke appeared first on Soccer News. Reported by SoccerNews.com 50 minutes ago.
The post Newcastle to go for Origi or Solanke appeared first on Soccer News. Reported by SoccerNews.com 50 minutes ago.
↧
More Pages to Explore .....
